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ABSTRACT
The following dissertation describes work performed to probe the biology of flatworms, with
a focus on anthelmintic development and target identification and validation. A wide range of
molecular and computational approaches were used to achieve this goal. In particular, I show
how free-living planaria can be utilized as a model for its parasitic relatives, for answering bio-
logical questions and for anthelmintic screening techniques. Through a variety of approaches,
I also contribute to the ongoing study and annotation of a large group of flatworm-specific
G protein-coupled receptors, the Platyhelminth-Specific Rhodopsin-Like Orphan Family. This
family is specific to the flatworms, is the largest clade of GPCRs and the largest taxonomically-
restricted gene family in the entire phylum, and a PROF representative may be preferentially
expressed in the neural tissue of planaria. Finally, using the PROF as a case study, I comment
on the task of functionally annotating GPCRs from parasitic worms and suggest a more wholis-
tic and rigorous approach. The entirety of this dissertation is then discussed, and the results
are reinterpreted through a lens that focuses on anthelmintic discovery and development.
1CHAPTER 1. OVERVIEW
This dissertation describes work performed to enhance the understanding of a large phy-
lum of invertebrates that houses several parasites of veterinary and public health importance,
Platyhelminthes. Particularly, it is basic research organized around two separate paths for drug
discovery: 1) utilizing free-living planaria as models in place of parasites and 2) focusing on
popular putative drug targets for further annotation, characterization, and validation.
This first chapter gives background on the organisms of interest, the diseases they cause, and
the current knowledge of drugs and drug targets in platyhelminths, also known as flatworms. It
also provides a general discussion on the state of drug development for parasitic platyhelminth
infections and describes four conceptual paths to anthelmintic development. Following are
three manuscripts that were produced through the course of the work for this dissertation.
Finally, these manuscripts will be connected and expanded upon in a concluding chapter, and
a suggestion of the next logical steps to take is included. Several appendices describe other
related contributions to published and not-yet-published work that was performed outside of
the scope of this dissertation.
1.1 Parasitic platyhelminths and the diseases they cause
Of the seventeen Neglected Tropical Diseases (NTDs) prioritized by the World Health Or-
ganization (WHO), four (schistosomiasis, foodborne trematodiases, taeniasis/cysticercosis, and
echinococcosis) are caused by taxa of the Platyhelminthes. Together, these diseases cause signif-
icant morbidity that severely inhibits the advancement and flourishing of developing countries,
particularly in sub-Saharan Africa (Table 1.1).
2Table 1.1: Neglected platyhelminthiases and their associated morbidity. Morbidity of platy-
helminthiases measured in disability-adjusted life years (DALYs), or healthy years lost due to disability or
early death.
Disease Genus Class DALYs (thousands)
Schistosomiasis Schistosoma Trematoda 3062.8
Foodborne Trematodiases Clonorchis, Fasciola, Opisthorchis, Paragonimus Trematoda 3634.8
Taeniasis/Cysticercosis Taenia Cestoda 341.2
Echinococcosis Echinococcus Cestoda 181.7
Parasitic flatworms reside in a small subphylum of Platyhelminthes called Neodermata
(Figure 1.1). These worms are characterized by their complex life cycles that traverse through
an intermediate host, either a freshwater invertebrate such as a snail or crustacean for the
Trematoda (Schistosoma, Clonorchis, Fasciola, Paragonimus, Opisthorchis) or an ungulate
for the Cestoda (Taenia, Echinococcus). The worms come to reside in humans by burrowing
through the skin or being ingested in food. Once parasites reach adulthood inside their definitive
host, the worms lay eggs that are excreted from the host through a variety of routes depending
on the species. The hatched eggs yield forms infective to the intermediate host, and the life
cycle is restarted.
Platyhelminth NTDs are targeted by the WHO for prevention and control in endemic areas
by so-called preventive chemotherapy (PC). As a public health concern, instead of treating
sporadic cases of platyhelminth NTDs after diagnosis, public institutions organize community
and regional-level administration of anthelmintics to at-risk individuals. PC helps to prevent
individual morbidity, but it also slows transmission of the infections by killing the worms before
they reach fecundity.
Mass drug administration (MDA) and community level PC have been incredibly effec-
tive [222]. However, widespread use of only a few drugs creates fear of the eventual selection of
resistant strains. Anthelmintic resistance is a serious problem in veterinary medicine (see [149]
for instance), strengthening fears that it will also become a public health concern. For this rea-
son, increased research of anthelmintic resistance, alternative strategies for platyhelminthiasis
control, new chemotherapeutics, and the basic biology of parasitic platyhelminths is necessary.
3Platyhelminthes
TrematodaCestodaMonogeneaTurbellaria
Parasitic
Free-living
Figure 1.1: Phylogeny of Platyhelminthes. The parasitic Neodermata (blue) and the free-living
Turbellaria, which includes planaria (red). Monogenea are ectopic parasites that do not infect humans or
animals of veterinary importance.
1.1.1 Schistosoma and schistosomiasis
Schistosomiasis is the most widespread and morbid of the platyhelminthiases. It is conser-
vatively estimated that 230 million people are currently infected, and it is endemic in much of
sub-Saharan Africa, which experiences 93% of the global disease burden [201, 84]. Schistosomi-
asis is caused by infection by flatworms of Schistosoma spp. Human infections primarily result
from S. mansoni, S. japonicum, and S. haematobium. Disease etiology and pathophysiology
differ by species. Urogenital schistosomiasis is caused by S. haematobium and is associated
with increased risk of bladder cancer and fibrosis of the bladder and kidney. Hepatic/intestinal
schistosomiasis is caused by S. mansoni and S. japonicum and is associated cirrhosis of the
liver. Unfortunately, symptoms are particularly severe in children, especially with repeated
infection, and they can result in growth stunting and reduced educational attainment [223].
The morbidity associated with both types of schistosomiasis is not primarily caused by
the adult flukes themselves, but instead by the chronic deposition of eggs by the adult female
worms. The genus Schistosoma is unique to the rest of the Neodermata in that it has evolved
sex differentiation (Figure 1.1). Upon maturity to fecundity, male and female schistosomes
pair in the mesenteric vasculature and can remain paired for the rest of their lives. Paired S.
mansoni living in the blood stream can lay up to 300 eggs per day [74]. These eggs circulate
throughout the vasculature until they pass through the intestinal wall into the gut lumen and
4are excreted, or until they become lodged in the host tissue. Eggs embedded in tissue cause
chronic inflammation, resulting the pathologies associated with the disease.
As mentioned, schistosomes have complex life cycles that go through an aquatic gastropod
mollusc intermediate host. After eggs are excreted in the feces or urine of the definitive host,
they hatch in fresh water as miracidia. Miracidia penetrate the snail host and develop to
sporocysts, where they clonally reproduce from mother sporocysts to daughters. Infective
cercariae are later released from snails back into the water, where they can find a definitive
human host (though S. japonicum can reside in other mammals as well) and burrow through
the skin into the vasculature. After entering, cercariae shed their tails and develop to juvenile
schistosomulae in the host’s blood. Schistosomulae circulate through the blood to the portal
blood of the liver, where they become sexually mature and form male/female pairs.
1.1.2 Others
The four foodborne trematodiases are caused by the consumption of food that harbors the
eggs of parasitic trematodes, typically raw fish, crustaceans, or vegetables (Table 1.1). These
diseases are indirect zoonoses do not depend on infection humans to complete the life cycle,
in contrast to schistosomes, for which humans are the most suitable definitive host. Instead,
foodborne trematodes cause pathology in humans when they are inadvertently eaten. Generally,
these diseases are asymptomatic but become severe when worm load becomes high in the organs
in which they live. For clonorchiasis and opisthorchiasis, adults worms live in the smaller bile
ducts of the liver where they can cause inflammation. Like S. haematobium, Chlonorchis
sinensis and Opisthorchis viverrini are carcinogenic and can cause mortality through bile duct
cancer. Fasciola spp. also reside in the liver, but these prefer the larger bile ducts and gall
bladder. Though noncarcinogenic, Fasciola can cause similar inflammation and fibrosis to that
seen by the other liver flukes.
Paragonimus spp. are classified as lung flukes, according to their preferred organ of habi-
tation. Clinical manifestations of lung fluke are diverse and can be mistaken for tuberculosis,
which confounds diagnosis because tuberculosis is often coendemic with paragonimiasis [113].
Worms can also travel ectopically, and symptoms become particularly dangerous when the
5flukes make it to the brain. Because of their residence in the lungs, lung fluke eggs are typically
expelled through the sputum rather than the urine or feces, though they are occasionally found
there as well [101].
Finally, zoonotic tapeworms of the genuses Taenia and Echinococcus are also foodborne,
but tapeworms are from the class Cestoda rather than the related Trematoda. These can be
acquired by consuming raw or undercooked beef or pork in the case of Taenia spp., or by the
inadvertent consumption of Echinococcus eggs that have been excreted from dogs, foxes, and
other Canidae, depending on the species. Taenia spp. develop to adults in the human small
intestine, where they can grow up to several meters in length. Though often asymptomatic,
larger tapeworms can cause digestive and stomach problems, but the most dangerous manifes-
tation of the disease is caused by the distribution of the larval cysts throughout the body. In
muscle, these cysts can cause pain and swelling, but cysts can also travel to the brain where
they can lead to adult-onset seizures. Similarly, Echinococcus granulosas also forms larval cysts
that distribute throughout the body. These can burst, releasing cystic fluid and causing severe
inflammatory reactions. In contrast, zoonotic Echinococcus multilocularis cannot fully mature
to cysts in humans and can asymptomatically live in humans for more than a decade. However,
as the immature cysts grow, they becomes tumour-like and can metastasize to other organs
and tissues, becoming fatal if left untreated.
1.2 Current drugs and their targets
Each platyhelminthiasis described above has an efficacious chemotherapeutic to treat it.
Indeed, schistosomiasis, chlonorchiasis, and opisthorciasis have been targeted by MDA strate-
gies [164]. Other foodborne trematodiases and tapeworm diseases, on the other hand, are
treated after clinical diagnosis.
1.2.1 Praziquantel
Praziquantel (PZQ) is an efficacious small molecule that resolves infections caused by trema-
tode adults and is used to combat schistosomiasis and foodborne trematodiases. Because it
results in the death egg-laying adults, PZQ is especially amenable for MDA programs by ab-
6lating the morbidity of the disease while also decreasing the rate of transmission through the
excretion of trematode eggs. PZQ was initially developed through a collaboration between
the pharmaceutical companies Bayer and Merck, and PZQ MDA programs progress through
strategic public-private partnerships, where industry partners provide the drug while public
bureaucracies oversee the administration.
PZQ was first developed for veterinary use in the late 1970s and was subsequently converted
for use as an anthelmintic for humans [170]. PZQ was discovered and characterized through
screening of whole animal infection models [11, 93]. Though decades old, the direct target for
PZQ is still unknown. Disruption of calcium homeostasis, and the resulting membrane blebbing,
and tegumental damage that the disruption creates, has long been known to be a significant
result of treatment [12], but the target of the mechanism of action is elusive. Evidence from
both schistosomes and free-living planaria indicate that voltage-operated calcium channels play
a significant role in PZQ’s effects [104, 144], but recent evidence also suggests that aminergic
G protein-coupled receptors might also be important [37].
Despite these unknowns, PZQ continues to be remarkably efficacious today, and tens of
millions are treated with it every year. The WHO’s most recent data indicate that over 53
million people were treated with PZQ in 2015, resulting in 28% coverage for those requiring PC
for schistosomiasis [227]. New models have suggested that continuing to increase coverage (and
expanding it to treatment of adults instead of just school-aged children) could result in disease
elimination [126]. Thus, the WHO has amended their MDA guidelines [228]. However, as PZQ
is the sole anti-schistosomal used for these campaigns and the treatment of choice for several
foodborne trematodiases, the selection for resistance is a lingering fear. Indeed, resistance can
be reproducibly selected for in the lab [60], and lower than expected PZQ efficacy has been
repeatedly reported in puncta throughout Africa [91, 48].
1.2.2 Oxamniquine
Oxamniquine (OXAM) was developed by Pfizer in the 1960s, before the arise of PZQ [173]
and its eventual usurpation of OXAM. OXAM kills both juvenile and adult worms, but it is
only efficacious against S. mansoni. For this reason, it was leveraged for MDA in Brazil until
72010, when OXAM resistant had become widespread [212]. Though resistance contributed to
the discontinuation of OXAM, OXAM had also been quickly superseded by PZQ because of
its higher efficacy, its ability to treat all types of schistosomiasis, and its cheaper synthesis and
administration.
OXAM resistance has been a useful case study for how anthelmintic resistance arises, and
it stimulated prediction that PZQ resistance may one day become a problem. It was re-
ported early that OXAM was metabolized by a S. mansoni sulfotransferase [163], and that the
metabolite inhibited DNA and RNA synthesis by associating with worm DNA [162]. Thus, it
was speculated that mutations to the sulfotransferase was the cause of resistance, and this was
recently confirmed [216].
1.2.3 Benzimidazoles
Two benzimadazoles (BZs) are used for the treatment of platyhelminthiases: triclabenda-
zole (TCBZ) for liver fluke and albendazole (ALB) for tapeworm infections [101]. Like other
anthelmintics, BZs were first developed for use in veterinary medicine, but these were discov-
ered in in vitro phenotypic screens rather than screens of infected animals [32]. TCBZ was first
used in veterinary practice in 1983 and in human medicine in 1989, after a liver fluke outbreak
in Iran [231]. ALB followed a similar trajectory: developed in the UK and first marketed in
1977 as a veterinary anthelmintic, and then approved for human use 10 years later [151].
BZs all target β-tubulin, and their use is more prevalent against nematode parasites than
flatworm parasites. Nevertheless, its mechanism of action remains the same for all species for
which it is utilized. By blocking the polymerization of tubulin, worms are unable to uptake
glucose and synthesize ATP, causing slow death. Like in nematodes, benzimidazole treatment
failure and resistance is widely reported in liver flukes [210, 29], but not yet in tapeworms [56].
1.2.4 The state of drug development for platyhelminthiases
The newest commercially available anthelmintic against platyhelminthiases is now almost
15 years old, and it is only used in Egypt and lowly efficacious [212, 232]. There are currently
no antischistosomals in clinical trials [212, 193], and there are none in the pipeline for any of
8the flatworm infections. Some have argued that, at least for schistosomiasis, new drugs might
not even be necessary, and instead focus should be given to strengthening public-private part-
nerships and improving MDA infrastructure [148, 193]. Furthermore, even if new drugs were
developed, it seems unlikely that they would provide more utility than PZQ, as was recently
concluded for two anti-malarials that were shown to have efficacy against S. haematobium [100].
Nevertheless, the fear of PZQ resistance and its lack of efficacy against juvenile worms drives
continued drug discovery efforts.
There are four main trajectories for anthelmintic development (Table 1.2). As noted, most
anthelmintics were discovered and developed through screens against infected animals models
like mice, rabbits, hamsters, or pigs. While the benzimidazoles arose from screens against
parasites in vitro, they are one success story among tens of millions of failures [66]. Currently, for
both chemical and reverse genetic screens, there are only three significant phenotypes available
for most medium-throughput measurement - motility, death, and morphology. There is hope
that additional and more sensitive phenotypic assays will increase the discovery rate, but this
is yet to be realized. In contrast, free-living flatworms have a more diverse range of phenotypic
assays, and some platyhelminth parasitologists hope to establish free-living planaria as a reliable
screening model for platyhelminth parasites (see below). However, even use of the robust and
pliable C. elegans has failed to elucidate any new nematicides [66], and it is unclear if planaria
are a better model for parasitic flatworms than C. elegans is for roundworms. Finally, it was at
one time prophesied that the genomic age would enable mechanistic-based drug development
in which putative targets, identified through basic research or in silico prioritization, would be
heterologously expressed and screened [67]. Unfortunately, this also has not come to fruition,
though it is still an active area of pursuit [38].
1.3 Anthelmintic discovery and development in an academic setting
While screening chemical libraries against infected model organisms has been the most
productive way to develop anthelmintics, the cost of these approaches is very limiting. Thus,
academic researchers who are interested in contributing to anthelmintic discovery and develop-
ment are compelled to look to alternative strategies (Table 1.2). These may not be as suited to
9Table 1.2: Trajectories for anthelmintic discovery.
Trajectory Technique Relative Cost Throughput Proximity to
Translation
Positive Results
1. Infected model organism Chemical screen $$$$ * **** Lead compound
2. Parasite in vitro
Chemical screen
Genetic screen $$$ * ***
Lead compound
Biological conclusions
3. Planaria in vivo
Chemical screen
Genetic screen $$ *** **
Lead compound
Biological conclusions
4. Drug target heterologous expression Chemical screen $ **** ** Lead compound
provide leads that are easily translated to medicine, but they do provide worthwhile byproducts
that may not be directly related to anthelmintic development.
For example, while screens of parasites or free-living models may not result in a lead com-
pound, initial hits can be directed toward a track that is more interested in the biology of the
organism and the biological mechanism of the chemical itself. Likewise, reverse genetic screens
are useful for functional annotation of genes, because they are more interested in the target
than the chemical. This is to say, misses in screens against parasites or free-living models
is not necessarily a complete waste of time and money; valuable data can be gleaned from
these experiments. In practice, the same cannot be said for the mechanistic-based screens in
heterologous expression systems. These may provide leads, but they are much less likely to
provide important data about the biology of the worm. However, these screens are typically
the ultimate experiment at the end a long pipeline of target identification, annotation, and
validation, all of which are worthy pursuits in and of themselves.
Thus, in an academic setting, researchers have the choice of which approach to take based
on the general aims of the laboratory, as well as the availability of a labor force and specialized
equipment or knowledge. This dissertation focuses on contributions that were made for two
of the four approaches: the development of free-living models for in vitro screens and the
construction of pipelines that prioritize putative drug targets. In addition to discussing the
translational capacity for these contributions, focus is also given to the biological conclusions
that resulted from this work.
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1.3.1 Platyhelminth models for in vitro screens
Though C. elegans as a screening model for nematicides has yet to cultivate any new nemati-
cides, there remains momentum to continue its use [26]. In addition to screening, both classical
and innovative comparative studies between C. elegans and parasitic nematodes pervade the
recent literature, and this pattern will continue [194, 161, 235].
In contrast to the nematodes, the use of free-living flatworms as models for their parasitic
phyla-mates is relatively recent [44, 39, 37, 36]. This is partly historical - C. elegans has
been a popular eukaryotic model for decades, and it was the first multicellular organism to
have its genome solved [28]. Thus, its utilization as a model for parasites was only natural.
Planaria, on the other hand, are not nearly as popular, and the first planarian draft genome of
Schmidtea mediterranea was not published until much later [176]. Even then, the genome was
so fragmented that it was onerous to use, and it required frequent updating [178]. Additional
transcriptomes were added to aid gene discovery and annotation [115, 172, 6, 3, 20], but there
was disagreement on the best species of planaria to use [40, 155]. Although S. mediterranea
was the first free-living flatworm to have a sequenced genome and database of ESTs, they were
in many ways unusable. Further, S. mediterranea is somewhat difficult to culture in the lab
and not commercially available.
Compared to parasitic platyhelminths, planaria are easier to culture in the lab and are
amenable to reverse genetics and other molecular tools. Furthermore, because of their rich
history in the fields of regeneration and stem cell biology, there is a greater breadth of pheno-
types available for assay. The recent discovery of neoblasts, the totipotent stem cells that give
planaria their unsurpassed regenerative capacity, in schistosomes [45, 219] and tapeworms [24]
has served to further strengthen the idea of planaria as a model for parasites. Toxicological
[76] and reverse genetic screens [179, 221] of planaria have been reported, but whether or not
this model can generate to new anthelmintic leads remains to be seen.
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1.3.2 Approaches for target prioritization and validation
In addition to these planarian resources, there are now dozens of platyhelminth parasite
genomes available for comparative analyses [214, 165, 86]. Comparative and subtractive ge-
nomics will be important techniques to identify attractive drug targets in these pathogens and
prioritize those that should be screened through heterologous expression (Table 1.2) [207, 131].
Crucial to this endeavor is the precise prediction and annotation of the millions of genes in-
cluded in these datasets. Toward this end, automated approaches can perform ab initio and
extrinsic gene finding and annotation [19, 34, 80]. Other more directed approaches give par-
ticular attention to superfamilies of genes that are conceptualized as attractive drug targets.
For example, most parasitic flatworm genome publications include glosses of G protein-coupled
receptors (GPCRs), ion channels, kinases, and others [214, 18].
GPCRs in particular are often highlighted not only because of their therapeutic potential,
but because they are readily identifiable in well assembled genomes. Open-reading frames can
be scanned in silico, and hydrophobicity plots can be constructed for each predicted gene in the
genome. Because of their canonical and invariable 7 transmembrane (TM) domain structure,
GPCRs can be unbiasedly annotated with few false positives (there are non-GPCR proteins
with a flipped 7TM topology, but so far these seem to be constrained to arthropods [16]).
This approach has been used in several GPCR identification projects for worms throughout
the phylum, including S. mediterranea, S. mansoni, S. haematobium, and four different tape-
worms [214, 236, 33]. Once the entire GPCR complement is identified, downstream analyses
can engage in more precise functional annotation, phylogenetic inference, and, eventually, ex-
perimentation and ligand validation.
The power of comparative genomics for GPCR identification, annotation, and prioritization
is increased with each new flatworm representative. With enough data from across the phylum,
focused analysis of specific gene families can reveal interesting phenomena, such as:
• the contraction or expansion of subfamilies,
• the proliferation of taxonomically-restricted and lineage-specific subfamilies,
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• correlations between binary presence/absence of subfamilies with organismal life history
traits, and
• divergence between host and parasite GPCR complements.
Broad comparisons such as these serve to provide the foundation for hypothesis-driven research,
and they are valuable datasets for a community interested in GPCRs as putative drug targets.
A phylum-wide briefing of the GPCR complements of each flatworm with a sequenced genome
would be a welcome addition to the conglomerate of data at hand for validation as drug targets.
1.3.3 A GPCR target case study
Until recently, the genomes of S. mansoni and S. mediterranea were the only platyhelminth
genomes available. Comparisons of these two datasets identified several interesting gene families
for further study, but, with only two flatworm genomes available, many of the inferences listed
above could only be made with heavy caveats. From these preliminary analyses, the most
compelling subfamily of GPCRs was the Platyhelminth-Specific Rhodopsin-Like Orphan Family
(PROF) [236]. This subfamily was the largest GPCR clade in both flatworms, and its members
showed no sequence similarity to any other protein in the entire metazoan database. PROFs
retain the canonical features of GPCRs - 7 TM domains, predicted intracellular C-terminus
and extracellular N-terminus, and the E/DRY motif on TM3), However, at this time, several
questions remained, including:
• the extent to which the PROF is found in the rest of the phylum,
• the veracity of the family’s lineage-specific expansion,
• the biological functions of the PROF members, and
• the ”druggability” of the PROF receptors [153].
At the time, many of these questions could not be answered, but the recent expansion in
flatworm genomic data allows for a renewed look at this compelling family.
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1.4 Dissertation Organization
The following chapters describe work done to increase the applicability of the third and
fourth anthelmintic discovery methods described in Table 1.2. Specifically, chapter 2 describes
the sequencing of the transcriptome of Dugesia tigrina, a planaria that is proposed as a model
for parasitic platyhelminths. Chapter 3 describes comparative work that sought to further
describe and annotate the PROFs and conjecture upon their druggability. Chapter 4 is an
opinion piece that discusses the importance of accuracy and precision in our gene annotation
protocols, and is uses the history of the PROF annotation as a case study to demonstrate where
annotation efforts can go wrong and mislead. Finally, chapter 5 discusses how chapters 2-4 fit
into the general framework of anthelmintic discovery, and it provides reasonable next steps for
how this work can be extended.
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CHAPTER 2. FUNCTIONAL ANALYSIS OF DUGESIA TIGRINA
TRANSCRIPTOME SEEDS PIPELINE FOR ANTHELMINTIC TARGET
DISCOVERY
A paper published in the Journal Parasites and Vectors
Nicolas J Wheeler1,2,3, Prince N Agbedanu1, Michael J Kimber1, Paula A Ribeiro4, Tim A
Day1,2, Mostafa Zamanian45
2.1 Abstract
Neglected diseases caused by infection by parasitic flatworms (platyhelminthes) impose a
massive hindrance to the continued progress of the developing world. While basic research on
flatworm parasites has increased over the past decade, researchers have yet to broadly adopt or
establish a free-living model as a complementary approach to studying these parasites. Planaria
are free-living flatworms best known for their robust regenerative capacities and have recently
attracted greater attention as model organisms for their parasitic relatives. Here, we report
the high-coverage sequencing and de novo assembly of the transcriptome of Dugesia tigrina,
a planarian widely utilized in the laboratory. The transcriptome of this model organism was
annotated and used to seed a pipeline for the rational prioritization and validation of puta-
tive drug targets. Following extensive orthology analysis, a small number of targets conserved
between parasitic and free-living flatworms were comparatively interrogated. As proof of prin-
ciple, it is shown how RNAi and pharmacology in the more convenient planarian model system
1Department of Biomedical Sciences, Iowa State University, Ames, IA USA
2Interdepartmental Genetics and Genomics, Iowa State University, Ames, IA USA
3Primary researcher and author
4Institute of Parasitology, McGill University, Ste. Anne de Bellevue, Quebec, Canada
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can both inform parasite biology and serve as an efficient screening tool for the identification
of lucrative anthelmintic targets.
2.2 Author Summary
The phylum Platyhelminthes includes a number of important human pathogens that inflict
a devastating global health burden. Free-living members of this phylum are best known for
their robust regenerative capacities and have more recently been forwarded as model organisms
for their parasitic relatives. To further this paradigm, a de novo transcriptome was assembled
for the planarian Dugesia tigrina across a set of dynamic conditions, followed by annotation and
extensive orthology analysis with respect to trematode (blood fluke) and cestode (tapeworm)
sequence data. A drug target prioritization scheme was implemented, where the investigation
of select targets in planaria can act as a convenient and tractable first-pass screening platform
for evaluating the druggability of corresponding parasite homologs. As proof of principle, three
planarian-parasite ortholog groups were probed with a mixture of RNAi and pharmacology
experiments. The results illustrate that this high quality D. tigrina transcriptome can serve as
a beneficial substrate for anthelmintic target identification, screening and prioritization.
2.3 Introduction
The Platyhelminthes (flatworms) comprise a diverse phylum of medically and economically
important species. Trematodes (flukes) and cestodes (tapeworms) are the etiological agents
of several Neglected Tropical Diseases (NTDs) that disproportionately devastate the health
and economic prospects of the poor across much of the developing world. Schistosomes infect
over 220 million in sub-Saharan Africa alone, and 600-800 million live at risk of infection
worldwide [226]. Echinococcosis and cysticercosis, while less prevalent than schistosomiasis,
are zoonotic parasitic diseases of great public health importance. These neglected diseases
inflict significant morbidity and mortality, accounting for upwards of 280,000 deaths and an
annual loss of between 3.5 - 70 million disability-adjusted life years (DALYs) [217, 140].
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The prioritization of flatworm-associated NTDs by the World Health Organization un-
derscores the urgency of efforts to control infection and to develop new anthelmintic treat-
ments [211]. The threat of drug resistance further calls attention to the need for novel pipelines
for drug target validation and drug discovery [220, 69]. Against this backdrop, free-living flat-
worms represent a new and potentially powerful screening model for parasite drug discovery
efforts [41]. Planaria of the free-living Turbellaria are widely interrogated in the realm of stem
cell biology due to their remarkable regenerative abilities [192]. In comparison to their parasitic
counterparts, planarians are much more amenable to modern genetic protocols and their cul-
ture and maintenance within the laboratory is relatively cheap and simple. Many behavioral,
biochemical, and morphological phenotypes have also been described for planaria, enabling
straightforward inferences of function from combined reverse genetic, pharmacological, and
phenotypic analyses [238, 59, 169].
In the case of schistosomes, it is necessary to maintain active populations of freshwater
snails as intermediate hosts, manage periodic shedding of the infective cercariae, induce trans-
formation to schistosomula or allow for penetrance into a definitive host (usually mice). The
process is difficult, time consuming, moderately dangerous, and, for many labs, cost prohibitive.
These concerns underpin efforts to extend the utility of planarian biology to the study of nearly-
related parasites [43], mirroring the important role that Caenorhabditis elegans has played in
furthering our understanding of the biology of parasitic nematodes [70].
A number of planarian species see use in the laboratory, with varying modes of reproduction,
regenerative potential, and genome ploidy. Schmidtea mediterranea is among the most widely
studied species. Clonal lines of S. mediterranea have been propagated to mitigate genetic
heterogeneity, and both genomic and transcriptomic data have been published for this stable
diploid [177, 3, 64, 172, 199]. Other notable planarian species include Dugesia tigrina and
Dugesia japonica[143]. Genome assembly and analyses are partly complicated in these species
due to their mixoploid genomes and the presence of large numbers of transposable elements [65].
No significant sequence resources yet exist for D. tigrina, despite the convenient commercial
availability of this species and its broad adoption in the fields of regeneration, pharmacology
and learning and memory [107, 154, 168].
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The emergence of a comprehensive sequence resource for D. tigrina will open avenues for
more precise biological manipulation of these planaria. RNA-Seq provides a powerful platform
for producing a high-coverage transcriptome, without the complications of whole genome as-
sembly. The selection of D. tigrina for this undertaking presents a reasonable trade-off, whereby
some level of genetic heterogeneity is accepted for the greater ease of procuring, maintaining
and scaling colonies, in comparison to clonally-derived laboratory strains. This is ultimately
beneficial in the scope of our aims and isn’t of consequence to the viability of the planarian-
parasite model paradigm. Genetic variation within this sexual strain is minor with respect to
the accepted genetic distance between planaria and the flatworm parasites for which they are
to serve as models. Although computationally intensive in the absence of a reference genome, a
high-quality de novo transcriptome assembly would allow for closer examination of our overar-
ching hypothesis that D. tigrina could provide a shortcut to identifying potential drug targets
in the phylum.
2.4 Results and Discussion
2.4.1 De novo transcriptome assembly
To help improve the odds of capturing transcripts in a more comprehensive manner, RNA
was isolated from D. tigrina across a set of dynamic conditions. Planaria were passaged through
a feed-starve cycle under different conditions prior to RNA extraction (Figure 2.1A). Worms
were left untreated, cut transversely, and cut tranversely while incubated in the presence of the
biogenic amine serotonin (5-hydroxytryptamine: 5HT). The aim of bisecting planaria was to
illicit activation of potentially dormant regeneration-associated transcripts [98]. Serotonin was
included due to its abundance and wide distribution in flatworm nervous systems, as well as
the fundamental role it plays in parasite neuromuscular signaling [158].
Total RNA was extracted and assessed for quality in preparation for Illumina paired-end
(2x100 bp) RNA-Seq. Read sets were combined for adapter-trimming, quality control and de
novo assembly using two independent pipelines. Trinity [72] was used alongside a multiple k-
mer (k = 21, 25, 29 and 33) Velvet/Oases [237], [191] pipeline to produce initial assemblies, as
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depicted in Figure 2.1B. The Trinity assembly was filtered at a low abundance threshold after
transcript abundance estimation vis RSEM [121]. The final Trinity (Assembly-T) and Velvet
(Assembly-V) assemblies exhibit similar statistical profiles, with a comparable total transcript
count, mean transcript length, N50, and transcript length range (Figure 2.1B). Both assemblies
compare very favorably to other published planarian assemblies, due in part to the large read
count and the computationally expensive incorporation of all available reads [3, 64, 143].
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Figure 2.1: RNA-Seq workflow. A) Planarian feed-starve cycle and RNA extraction timeline. B)
Processing of raw reads and parallel de novo transcriptome assembly using the Trinity and Velvet/Oases
pipelines. The table depicts relevant statistics for the transcriptomes and predicted proteomes associated
with each pipeline through various post-assembly filtering stages.
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2.4.2 Protein prediction and transcriptome annotation
Predicted proteomes were created for each assembly using Transdecoder
(http://transdecoder.sourceforge.net/) to evaluate the coding potential of open reading frames
based on codon usage. After subtraction of redundant proteins, the Assembly-T proteome had
a marginally larger unique protein count and was therefore used for all subsequent analysis.
The 22,363 predicted proteins from this dataset were used in blastx queries against the NCBI
nr database [30]. 16,467 sequences had at least one significant hit (E-value < 0.001) and the top
20 hits were retained for each sequence. We then applied Gene Ontology (GO) annotations to
the de novo transcriptome using the Blast2GO pipeline [46]. The mapping of sequence-specific
blast results to GO identifiers resulted in functional annotation of all 16,467 proteins with
significant blast hits, accounting for 73% of the predicted proteome. This was complemented
by InterProScan domain mapping, resulting in the identification of at least one domain for
18,051 protein sequences [95].
Annotated predicted proteins were categorized according to their involvements in various
biological processes at different hierarchy levels. Figure 2.2 depicts this categorization from
more general level 2 categories through more specific level 6 categories, with many proteins
binned into multiple categories. Separately, to further gauge coverage of core pathways, Kegg
pathway mapping was carried out [97]. As a representative example, over 95% of the reference
glycolosis pathway enzymes were identified (data not shown). The very small numbers of
unmapped enzymes in these and related metabolic pathways could plausibly also result partly
from fundamental biological differences, as opposed to gaps in our dataset.
21
0.56%  Viral reproduction
7.23%  Signaling
9.29%  Response to stimulus
1.89%  Reproduction
6.17%  Multicellular organismal process
0.22%  Multi-organism process
17.81%  Metabolic process
6.92%  Localization
1.12%  Growth
7.01%  Developmental process
2.17%  Death
19.04%  Cellular process
6.70%  Cellular component organization or biogenesis
1.17%  Cell proliferation
12.68%  Biological regulation
Level 2
0.14%  Secondary metabolic processes
2.80%  Response to stress
1.01%  Response to external stimulus
0.63%  Response to endogenous stimulus
0.42%  Response to biotic stimulus
0.62%  Response to abiotic stimulus
0.74%  Regulation of biological quality
9.76%  Regulation of biological process
11.58%  Primary metabolic process
4.81%  Nitrogen compound metabolic process
4.82%  Multicellular organismal development
8.04%  Macromolecule metabolic process
1.32%  Macromolecule localization
0.17%  Interspecies interaction between organisms
5.41%  Establishment of localization
3.44%  Anatomical structure development
0.86%  Behavior
3.61%  Biosynthetic process
3.55%  Catabolic process
5.95%  Cell communication
1.83%  Cell cycle
1.69%  Cell death
0.22%  Cell growth
0.06%  Cell recognition
0.91%  Cell-cell signaling
5.25%  Cellular component organization
2.88%  Cellular component organization or biogenesis at cellular level
2.86%  Cellular development process
0.74%  Cellular homeostasis
8.67%  Cellular metabolic process
5.20%  Cellular response to stimulus
9.20%  Transport
0.30%  Symbiosis, encompassing mutualism through parasitism
8.83%  Signal transduction
0.25%  Regulation of metabolic process
8.83%  Regulation of cellular process
10.72%  Protein metabolic process
2.25%  Protein localization
8.17%  Nucleobase-containing compound metabolic process
5.19%  Anatomical structure morphogenesis
1.46%  Carbohydrate metabolic process
4.86%  Cell differentiation
1.27%  Cellular biosynthetic process
4.89%  Cellular component organization or biogenesis at cellular level
10.47%  Cellular macromolecule metabolic process
8.17%  Cellular nitrogen compound metabolic process
2.37%  Embryo development
1.51%  Gene expression
0.71%  Generation of precursos metabolites and energy
1.25%  Homeostatic process
1.68%  Lipid metabolic process
1.27%  Macromolecule biosynthetic process
6.35%  Macromolecule modification
Level 3 Level 4
0.85%  Regulation of macromolecule metabolic process
21.85%  Protein modification process
16.79%  Organelle organization
11.78%  Nucleic acid metabolic process
10.83%  Ion transport
7.74%  Establishment of protein localization
25.79%  Cellular protein metabolic process
4.37%  Cellular macromolecule biosynthetic process
Level 5
7.83%  Translation
1.53%  Regulation of gene expression
13.87%  Protein transport
3.72%  Mitochondrian organization
12.76%  Cytoskeleton organization
39.16%  Cellular protein modification process
21.12%  DNA metabolic process
Level 6
Total: 31,097
Total: 39,738
Total: 21,221
Total: 6,797
Total: 3,792
Figure 2.2: Comprehensive annotation of RNA-Seq transcripts. GO annotations reveal the wide
range of biological process associated with the D. tigrina predicted proteome. Level 2 categories provide the
most general functional annotation, with the largest fraction of proteins assigned to cellular and metabolic
processes. The majority of signal transduction related proteins are captured in Level 4 annotations, and
Level 6 annotations contain predictions for smaller numbers of proteins implicated in more specialized
pathways (e.g. protein modification and DNA metabolism).
2.4.3 Identification of differentially expressed transcripts
While the inclusion of different treatment conditions was primarily aimed at increasing
transcript capture, it also presents an opportunity to identify transcripts that are significantly
upregulated or downregulated with respect to these conditions. Previous investigators have car-
ried out experiments to identify regeneration-associated genes in S. mediterranea by performing
RNAi screens to perturb normal regeneration [169]. While many transcripts show greater than
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four-fold differences in expression between control and cut worms (e.g. RNA-dependent RNA
polymerase, RNA helicases, reverse transcriptase), these data do not lend themselves to facile
implications of molecular mechanisms of regeneration and are provided for further examination
and investigation (see Additional Materials).
2.4.4 Identification of planarian-parasite orthologs
The sequencing and assembly of the D. tigrina transcriptome allows for an important ge-
netic comparison between this free-living worm and its pathogenic relatives. Proteinortho was
used to identify orthologous protein sequence groups shared between and among D. tigrina
and the parasitic species Schistosoma mansoni and Echinococcosis multilocularis [118]. This
program employs an efficient reciprocal best alignment algorithm, yielding a very conservative
but reliable subset of likely ortholog groups using the predicted proteomes of a set of species. A
total of 3,179 orthologs were identified for the D. tigrina - S. mansoni pairing, contrasted with
a more expansive pairwise homology (BLASTp) search which identifies over 10,000 significant
(E-value > 0.01) hits. Overall, 2,693 sequences were identified as belonging to ortholog groups
that spanned all three species (Figure 2.3).
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Figure 2.3: Protein-level orthology among free-living and parasitic flatworms. Orthology analy-
sis via Proteinortho identified 2,693 orthologues shared among all 3 flatworms, and several hundred between
flatworm pairs. In this high-stringency approach, the majority of D. tigrina transcripts were not identified
as bona fide orthologs, despite substantial sequence homology.
To better visualize these relationships, a Circos diagram was created that mapped the chro-
mosomal arrangements of orthologous genes for the selected parasites (Figure 2.4) [110]. Given
that a stand-alone transcriptome lacks this spatial information, D. tigrina transcripts were
arbitrarily ordered to allow for the mapping of planarian transcripts to the parasite genomes.
Figure 2.4A and Figure 2.4B show pairwise individual sequence comparisons between D. tig-
rina and the two parasites. The ideograms highlight the genomic locations of identified par-
asite orthologs, and are surrounded by heatmaps that display the percent sequence similarity
shared for each planarian-parasite ortholog pair, as well as for each parasite sequence and its
nearest-matching human homolog, identified with BLASTp searches against the RefSeq human
proteome.
24
 90-100
 80-89
 70-79
 60-69
50-59
 40-49
 30-39
 20-29
 10-19
 80-100
 60-79
 40-59
vs Human
vs Planarian
Gene Ontology (GO) mining for putative drug targets
GO:0003824     catalytic activity
GO:0004872     receptor activity
GO:0004930     G-protein coupled receptor activity
GO:0005216     ion channel activity
GO:0006810     transport
GO:0016020     membrane
GO:0016021     integral to membrane
GO:0016301     kinase activity
GO:0016791     phosphatase activity
GO:0034702     ion channel complex
GO:0043235     receptor complex
     Tape
worm  Fluke
Protein homology heatmaps
PPOS (% of positive scoring matches)
     
D. 
tig
rin
a
     D. tigrina
1
2
5
3
4
6
7
W/Z1
2
3
4
5
6
7
8
9
E. multilocularis orthologs S. mansoni orthologs
A B
C
Figure 2.4: Mapping of orthology relationships between D. tigrina and the genomes of pathogenic
flatworms. A and B) Circos diagrams depicting ortholog pairs between arbitrarily arranged D. tigrina transcriptome
and the genomes of the tapeworm E. multilocularis and the blood fluke S. mansoni. C) Ideograms are shown for
E. multilocularis and S. mansoni chromosomes. Physical ortholog links reveal synteny between these parasites for
putative drug targets. Links are shown only where there exists a D. tigrina ortholog. Drug targets were extracted by
mining the D. tigrina predicted proteome for GO terms displayed in the box on the right. The inner heat map shows
the percent similarity (ppos) between parasite and planarian ortholog protein pairs, and the outer heat map shows
similarity between a given parasite protein and its nearest human homolog (RefSeq).
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2.4.5 Drug target prioritization
Ortholog groups with high sequence conservation through the phylum represent potential
broad-spectrum therapeutic targets, and these can plausibly be interrogated using D. tigrina as
a more tractable free-living model. Ideally, we want to prioritize planarian protein targets that
share very high sequence similarity with both fluke and tapeworm homologs, and that exhibit
lower levels of sequence similarity with any identifiable host (human) proteins. Figure 2.4C
applies this selection logic towards exploitation of the available sequence data. Here, links
between S. mansoni and E. multilocularis reveal synteny for those orthologous gene pairs that
share a highly similar D. tigrina ortholog and which represent lucrative anthelmintic targets.
The final links are restricted to a set of 441 putative drug targets, filtered from the initial set
of 2,693 ortholog groups.
To estimate the druggability of protein targets, we utilized GO annotations that are most
often associated with established drug target classes, which are found at DrugPort. Highly-
associated GO terms, manually supplemented, were collected into a list and used to extract
specific sequences from the annotated ortholog dataset. Within this set, we looked to identify a
handful of targets as proof of concept for our model paradigm. Specifically, three targets were
chosen that showed high sequence similarity between free-living and parasitic flatworms and
that we could potentially pharmacologically manipulate or inhibit with commercially available
chemicals. These targets were actin-related protein complex 2/3 subunit 2 (ARPC2), succinate
dehydrogenase (SDH1), and NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2).
2.4.6 Comparative chemical screen of targets
To carry out a comparative first-pass phenotypic screen, chemical inhibitors for each target
were used to treat newly transformed S. mansoni schistosomula and planaria across a range of
concentrations. It should be noted that these chemical inhibitors were first developed to act
on mammalian proteins, and the specificity of each interaction is therefore unknown. However,
there is significant sequence conservation between protein domains in these proof of concept
targets and their human homologs (Additional Materials Figure 2.11 - Figure 2.13), suggesting
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a high likelihood of a conserved mode of action. For example, Dugesia ARPC2 shares 58%
sequence identity with its human counterpart. While it can be hypothesized that CK-666,
which locks this complex in an inactive state [81], performs this action in flatworms as well, it
can not be necessarily inferred.
Motility phenotypes were measured in terms of body contractions (bends per second) for
S. mansoni and average velocity (mm per second) for D. tigrina. As shown in Figure 2.5, the
dose response curves for each chemical elicited a similar phenotypic response profile for both
S. mansoni and D. tigrina. CK-666 (ARPC2 inhibitor) and 3-nitropropionic acid (3-NPA;
SDH1 inhibitor) caused dose-dependent decreases in motility in both worms. In contrast,
rotenone (NADH dehydrogenase inhibitor) did not alter either worm’s motility. This further
evidences the notion that pharmacological manipulation of highly conserved flatworm molecules
in planaria can be predictive of phenotypic outcomes in schistosomes. One target that brought
about a phenotypic effect in the pharmacological screen, ARPC2, and one that showed no
apparent effect, NDUFV2, were then further examined with RNA interference (RNAi).
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Figure 2.5: Comparative effects of pharmacological inhibition on motility. A-C) Pharmacolog-
ical inhibition of three putative targets leads to correlative motility phenotype in free-living (D. tigrina)
and parasitic flatworms (S. mansoni). Chemical inhibitors of ARPC2 (A) and SDH1 (B) caused a dose-
dependent decrease in motility in both species as measured by contractions per second (schistosomula) or
millimeters of translational movement per second (planaria). Chemical inhibitor of NDUFV2 (C) did not
have any dose-dependent effects in either organism. Nonlinear regression is fit to a four-parameter variable
slope model; log(inhibitor) vs. response. Bars represent SEM.
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2.4.7 RNAi in planaria is predictive of phenotypes in parasites
Complementary to the pharmacological screen, the expression of ARPC2 and NDUFV2
was suppressed using RNAi. After three dsRNA feedings dispersed over a 7 day timeline,
semi-quantitative PCR was used to confirm near-complete transcript knock-down (Figure 2.14
- Figure 2.15). Phenotypic analyses were carried out on D. tigrina by monitoring motility
and regeneration as commonly assayed outcomes of gene suppression in planaria. Motility was
not significantly altered for either experimental group (Figure 2.6A), although this might be
expected for NDUFV2 considering chemical inhibition resulted in no motility phenotype.
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Figure 2.6: RNAi phenotypes correlate to pharmacology screen. A) Comparative pharmacology led to the
selection of ARPC2 (increased motility) and NDUFV2 (no noticeable phenotype) as proof of principle targets for
RNAi-mediated knock-down. RNAi of both targets did not bring about any significant changes in planarian motility.
However, ARPC2 suppression was lethal to regenerating D. tigrina. These observations correlate to the pharmacology
screen where no phenotype was observed with application of NDUFV2 inhibitor, but stark motility phenotypes were
observed with ARPC2 chemical inhibitor. B) Survival curves show significantly decreased (P < 0.0001; Log-rank
Mantel-Cox test) rates of survival for ARPC2(RNAi) cut worms in comparison to control cut worms. C) Prior to
death, caudal fragments of ARPC2(RNAi) cut worms showed impaired sealing of the initial wound and improper
blastema formation. Proper eye spot formation can be observed in control worms (red arrows) and is absent in the
ARPC2 suppressed worms.
To assay regeneration, worms were bisected above the pharynx and each half was maintained
in a separate well. Cephalic and caudal regeneration was observed over the course of 2-3
weeks. No developmental phenotype was observed for Dtig-NDUFV2(RNAi) worms, however,
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Dtig-ARPC2(RNAi) worms showed aberrant regeneration in comparison to control worms,
consisting of a range of specific outcomes that included stalled or slowed regeneration, blastema
malformation, an inability to seal the wound, and eventual death (Figure 2.6B and Figure 2.6C).
In these assays, readily identifiable phenotypes were observed in planaria that were predictive
of visible phenotypes in the comparative chemical screen.
This proof of principle was limited to a handful of putative targets with commercially avail-
able inhibitors, but the pipeline can readily be scaled to larger numbers of targets. In the pro-
posed scheme, highly conserved planarian-parasite orthologs are first interrogated with RNAi
in planaria. The detection of aberrant phenotypes relating to planarian motility, morphology,
or regeneration can serve as an efficient and high-throughput filter for target druggability in
flatworm parasites. Parasite orthologs can then be investigated using available techniques such
as RNAi and heterologous expression for drug target validation and functional characteriza-
tion. This approach sidesteps the often prohibitive costs and technical challenges of carrying
out large high-throughput screens in transient parasite life stages.
2.5 Conclusion
This work further promotes the adoption of planaria, and in particular D. tigrina, as a
model screening organism for candidate drug targets in parasites. We provide a high-coverage
annotated de novo transcriptome as a substrate for such efforts. The identification of ortholog
groups that extend to planaria, blood flukes, and tapeworms, allows for the rational prioriti-
zation of likely broad-spectrum drug targets that can be readily screened in D. tigrina. We
outline a pathway for the high-throughput evaluation of putative drug targets in planaria as a
prelude to validation and more extensive characterization in parasitic flatworms. We further
show how such screens can be predictive of biological phenotypes in parasites.
This study builds on other recent studies that have shown the utility of the planarian sys-
tem in understanding parasite biology. For example, the antischistosomal praziquantel has
been shown to lead to changes in planarian regenerative polarity through the action of voltage-
operated calcium channel (VOCC) β subunits [144]. In this conserved signaling pathway, regen-
erative polarity in planaria acts as a phenotypic correlate of drug efficacy and worm paralysis
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in schistosomes. This was followed by a more comprehensive investigation of the phenotypic
correlates of manipulating signal transduction pathways in the planarian D. japonica and the
parasite S. mansoni, as a predictive tool for the discovery of antischistosomal agents [50]. The
striking identification of adult stem cells in S. mansoni that resemble planarian neoblasts further
strengthens the notion of fundamental biological conservation between free-living and parasitic
flatworms [219]. The annotated D. tigrina sequence resource, along with the orthology-based
prioritization of putative drug targets, can act as a valuable substrate to help catalyze a low
cost and scalable in vivo pipeline for anthelmintic drug discovery.
2.6 Methods
2.6.1 Planarian culture and RNA isolation
D. tigrina (Ward’s Natural Science, Rochester, NY) colonies were maintained in aerated
spring water. Planarians were starved for one week prior to RNA isolation. Five animals were
randomly selected per experimental condition on day 7. Each group was washed repeatedly
with spring water and tissue grinding was carried out using mortar and pestle in the presence of
liquid nitrogen. A hybrid TRIzol (Invitrogen)/ RNeasy (Qiagen) protocol was used to isolate
total RNA from ground tissue, whereby supernatants from the chloroform phase separation
were combined with an equal volume of 100% ethanol and loaded into RNeasy columns for
purification. Total RNA quality and concentration was assessed with an Agilent Bioanalyzer
2100. RNA integrity number (RIN) proved to be a poor benchmark of RNA quality, as the
Dugesia 28S rRNA subunit is evidently converted into fragments that co-migrate with 18S
rRNA to produce a triple-peak, giving the misleading appearance of RNA degradation. All
samples yielded at least 1 ug/ul of RNA when eluted in 40 ul of H20, with an OD A260/A280
of ∼2.1 and OD A260/A230 of ∼2.2.
2.6.2 Library preparation and Illumina paired-end RNA-seq
Illumina HiSeq 2000 paired-end (2x100 bp) library preparation and sequencing was carried
out at the McGill University and Genome Quebec Innovation Center. The four RNA samples
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were multiplexed across two sequencing lanes with an average fragment size of ∼ 350 bp,
corresponding to an average insert size of ∼ 224 bp. The sequencer run yielded ∼ 30 million
paired-end reads per sample (241 million total paired-end reads) with an average Phred quality
score of 37.
2.6.3 De novo transcriptome assembly
Adapter sequences were trimmed and reads were passed through a sliding window quality
filter (window size = 4, minimum average quality score = 25) using Trimmomatic 0.22 [22].
Paired-end reads and singletons ≥ 50 bp in length were retained. Overlapping paired-end reads
were identified and merged using FLASH [132] with an expected insert size of 220 bp. Quality
control and read collapsing led to a total filtered pool of 165 million paired-end reads and 55
million singletons. Surviving reads were combined and fed into the Trinity [72] pipeline for de
novo assembly, performed on the GLUMEQ Guillimin supercomputer maintained by McGill
University. Assembly optimization and runs were carried out on a 1 TB ScaleMP node that
allows for a virtualized shared large memory environment required by the OpenMP standard.
Final assembly was carried out with a minimum k-mer coverage of 2 and the default k-mer size
of 25. Complex graphs that proved unresolvable within a 6 hour window were manually excised
to allow the assembly to proceed. Separately, an available Python script was used to feed the
same read pool into the Velvet [237] pipeline and to generate multiple k-mer assemblies (k =
21, 25, 29 and 33) for merging with Oases (k = 25) [191]. The minimum contig or transcript
length for both assembly pipelines was set to 200 nt. The statistical software R [208] was used
to generate and evaluate assembly statistics. Further bioinformatic analysis was restricted to
the Trinity transcriptome.
2.6.4 Transcriptome filtering and annotation
Filtered paired-end reads were mapped to the Trinity transcriptome with Bowtie [114].
Abundance estimation with RSEM [121] was used to select for transcripts that accounted for at
least 1% of the per-component (IsoPct) expression and that met a TPM cutoff of 1. Open read-
ing frames (ORFs) with coding potential were predicted from the final transcriptome using log-
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likelihood scores based on codon usage with Transdecoder (http://transdecoder.sourceforge.net/).
The resulting predicted proteome was further filtered with CD-HIT-EST [123] at a threshold
of 0.95. BLAST2GO [46] was used to functionally annotate the Dugesia predicted proteome
and to assign GO terms to predicted proteins.
2.6.5 Differential expression analysis
Condition-specific abundance estimation was carried out with Bowtie and RSEM using
the final filtered transcriptome. Existing Trinity scripts and the R/Bioconductor packages
DESeq and edgeR of the statistical programming language R were used to identify differentially
expressed transcripts. A threshold e-value of 103 and minimum four-fold expression changes
were used to select and cluster transcripts as either up or down-regulated. Transcript sets were
then mapped to previous annotations, where available.
2.6.6 Orthology analysis and drug target prioritization
Proteinortho [118] was used to detect ortholog groups between and among the D. tigrina,
S. mansoni and E. multilocularis predicted proteomes. The predicted parasite proteins were
downloaded from GeneDB [127]. The visualization tool Circos [110] was utilized to organize
and display the orthologous relationships among these species in the context of Turbellarode,
Trematoda, and Cestoda synteny. Provided that a transcriptome does not imply any spatial
or chromosomal arrangement, the D. tigrina transcripts were arbitrarily arranged on a pseudo-
chromosome - designated as an ideogram - to enable visualization. GFF files obtained from
GeneDB (S. mansoni) or personal communication (E. multilocularis) containing gene coordi-
nate data for the two parasitic species were parsed for necessary sequence features using a set
of in-house Python scripts and used to draw orthologous ”links” between ideograms. Heatmap
data was created by running command-line BLAST [30]. Similarity calculations were carried
out with D. tigrina orthologs as queries against their corresponding parasitic orthologs, as well
as with parasitic orthologs as queries against the RefSeq human proteome [166]. Sequence
homology was used to select orthologs that displayed high sequence similarity among the three
examined flatworm species, as well those sufficiently diverged from their nearest-identifiable
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human homolog. These prioritized ortholog groups were mined with GO IDs, along with
manually-selected IDs, to extract and highlight annotated sequences belonging to notoriously
druggable protein families.
2.6.7 Parasite maintenance
Snails (Biomphalaria glabrata) infected with S. mansoni were provided by the Biomedical
Research Institute (BRI) (Rockville, MD). Cercariae were shed from snails by light exposure and
subsequently mechanically transformed to schistosomula in vitro per existing protocols [136].
Somules were cultured in modified Basch medium (containing 10% Fetal Bovine Serum) at
37◦C in 5% CO2 atmosphere.
2.6.8 Schistosomula assays
Three small molecule inhibitors (CK-666, ARPC2; 3-NPA, SDH1; rotenone, NDUFV2)
were purchased from Sigma-Aldrich (St. Louis, MO). Newly transformed schistosomula were
incubated with varying concentrations of each inhibitor for 30 minutes and recorded at 10x
magnification for 5 minutes. The wrMTrck plugin of ImageJ [190] was used to track schistoso-
mules and quantify motility in terms of contractile rate (body bends per second; BPS).
2.6.9 Planarian pharmacology and motility analysis
Dugesia individuals were placed in 35 mm dishes filled with 4 mL of media supplemented
with inhibitor at varying concentrations or an equal amount of solvent control, and the dishes
were placed on a light box in a dark room. After 30 minutes of incubation, worms were recorded
for 5 minutes by EthoVision [146], and motility was quantified by dividing the parameter
DistanceTraveled (mm) by TimeInZone (s). Down-sampling was set to 5 to ensure that small
bending and twisting motions were not factored. Tracking profiles were visually diagnosed for
errors and manually edited where required. Errors were most often attributable to to light
reflections off of the surface of liquid media or imperfect arena definitions.
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2.6.10 Planarian RNAi and regenerative assays
Total RNA was extracted from homogenized D. tigrina and converted to cDNA with Am-
bion’s RetroScript RT kit. 600 bp sequences were PCR amplified using primers designed with
the online implementation of Primer3 [106]. T7 cites were added using a two-step PCR pro-
tocol, and dsRNA was created with the Ambion MegaScript RNAi kit. dsRNA was added
directly to homogenized liver paste according to prescribed methods [183] (10 umol/worm for
one hour). Feedings were performed on Days 1, 3, and 5, and worms were bisected immedi-
ately above the pharynx on Day 6. Two worms from each experimental group were set aside
for semi-quantitative RT-PCR performed with Ambion’s QuantumRNA18S Internal Standards
kit. Worms were observed for defects in regeneration over the full regeneration period (∼2-3
weeks).
2.7 Acknowledgments
Infected snails were provided by BRI via the NIAID schistosomiasis resource center under
NIH-NIAID Contract No. HHSN272201000005I. E. multilocularis GFF files were kindly pro-
vided by M. Zarowiecki. Nicolas J Wheeler was supported by fellowship funds from the Office of
Biotechnology, Iowa State University. We gratefully acknowledge Compute Canada/CLUMEQ
for access to valuable computational resources.
36
2.8 Additional Materials
Cu
t1
Cu
t2
Se
r1
Se
r2
Co
n3
Co
n4
Co
n1
Co
n2
comp96684_c011 04_c0co p98586_c0m 110908_c2co p 04852 01189 8_c2comp 7291 0
91587_c0co p1 602_c0m 31453co p70430_c01 8974_c0comp 05785113333_c0
co p95900_c0m 1022 9_c0co p 16 85 11 0719_c0comp 198 0103482_c0co p 18 29 1
m 1 6376_c0co p 1743 1102686_c0comp 442270354_c0co p1 9453_c1m 01339 0
co p1175 0_c26487 1comp114116_c0 379 2co p5121 _c0m 1 6674_c0co p87 52_c0
117 10_c0comp 4572110963_c1co p 164 0m 109514_cco p 13639 21 5365_c1
comp 047 7 2439483_c0co p1056 1 1m 6770_c0co p10806599163_c0comp114803_c1
9553 _c0co p112173_c0m 1032 1co p274585_c019109comp1 3517_c1019 4 0
co p1 7456_cm 3463_c0co p91 76_c087091comp105681_c083702_c0co p1014 9_c0
m 6101co p115836_c0743comp114395_c00752 1co p1 2144_cm 58603_c0
co p107245_c010329 1comp96845_c089 7co p113910_c0m 0149 1co p116681_c
95755_c0comp 707198966_c0co p105041_c0m 91250_c0co p 508991496_c0
comp101637_c07 356_c0co p99011m 77665_c0co p45 1116608_c2comp97174_c0
45206co p69069_c0m 116115_c1co p 0009688132_c0comp100101_c0317 22
co p94244_c0m 110666_c0co p425012109865_c0comp 1213994549_c1co p103032_c0
m 942 9_c0co p115389_c197977_c0comp8 06897853_c0co p7 667m 109261_c2
co p 7357 0118 40_ccomp 09688 18768 _c0co p68133m 5538_c0co p105042_c0
9394comp107567_c012148co p62775_c0m 100014_c0co p9999 _c066168 1
comp99531_c0260405_c0co p106951m 1 394_c1co p105653 00978_ccomp406 6 0
1 4128_c1co p 03056 0m 117812_c3co p 08697 066221_c0comp11 850_c007208
co p111 40_c0m 08468co p1 5291_c007106comp1 2420_c042323_c1co p115555_c3
m 96 1co p1067 1_c011546comp1 0883_c003606co p112078_c0m 0 2 3
co p1 2356_c007015comp11258 _c009463 2co p111656_c0m 3538co p9779 _c0
113178_c0comp 8330 111255 _c0co p 09712m 1 1230_c0co p 0880117622_c1
comp 0915 0109874_cco p 12919 0m 1 7 4_cco p96342_c01151 2_c1comp 0346 0
108089_cco p 11518 0m 100041_cco p 16905 01051 2_ccomp 10451 01 1535_c2
co p352893 0m 104046_cco p 18473 11057 2_c0comp97 12_c0101400_c0co p66957_c0
m 913co p109413_c0659comp100059_c017743 2co p65043_c1m 10 696_c0
co p86418_c09823comp10 20_c010738co p1 2416_c0m 46320_c0co p115197_c0
07725comp1189 1_c402006 0co p1132 3_cm 1989 1co p1135 8_c009 44 1
comp54583_c0103074_c0co p 10962m 1 4441_c0co p 11303 11 5232_ccomp 06023 0
97858_c0co p115 62_c0m 86689_c2co p100104_c089161_c0comp102257_c068309_c0
co p97085m 82724_c0co p109989_c097663_c0comp889813 790_c0co p10 410_c1
m 10356 0co p2770_c0352977_c0comp77588_c0108561_c0co p 15387 1m 106936_c
co p69275_c071816comp84123_c17 14 0co p106016_c0m 4970co p10 355_c1
11284comp1 2950_c305 38 0co p113807_c1m 87927_c0co p115515_c01 6
comp103518_c089408_c0co p 2124m 104 86_c0co p9 03 _c05222comp89 85_c1
106702_c1co p 267 0m 105905_cco p 16312 195815_c0comp607 61 9027_c0
co p 13949m 1 5 1_c2co p99136_c1103898_c1comp67771_c096546co p118237_c1
m 66691_c0co p111475_c2826 1comp112075_c01997 1co p110 35_c4m 7678 0
co p28531_c0116494_c2comp981 3_c0110789_c0co p20212_c0m 85348co p111099_c0
617comp11 281_c09814 _c0co p118561_c0m 0779 1co p118966_c03538 1
comp116394_c03120co p114252_c0m 0817co p94280_c1117483_c1comp70107_c0
116398_c0co p 7275 1m 115 4 _c0co p 032 3114916_c0comp 0565111244_c3
co p 0247 0m 99 95_c0co p114777_c003982comp6616 _c0109537_c0co p99741_c0
m 114921_c0co p 06809114477_c2comp 0 936 01 4342_c1co p 19203 0m 1 6516_c
co p 17449 017 163_ccomp75435_c0530 0co p112054_c0m 0432co p113288_c4
460 1comp118987_c0 794 0co p118 10_cm 7933 0co p115111_c1010 3 0
comp96836_c087489co p115685_c2m 7542 3co p113450_c0941 2comp114636_c0
39 7 1co p109544_c0m 17812 1co p1 284_c008116comp1 5307_c011836 3
co p1 5464_c1m 14 17 0co p108721_c17 7 0comp10 1 8_c19802 0co p1 1244_c1
m 86413_c0co p109 09_c09 072_c0comp1159 7_c09568co p21323_c0m 697 6
co p105719_c119194 0comp1 8500_c179 1 1co p102 70_cm 17933 1co p1 1066_c0
07135 1comp114979_c069781_c0co p106049_c1m 7686co p11 947_c05708 2
comp112285_c0061 0co p107824_cm 3 75 2co p116518_c878 8_c0comp113377_c0
0 268co p113133_c3m 98104_c2co p1126 1_c109264 0comp118597_c91 6 0
co p118490_c2m 0306 0co p11 2 1_c9085 0comp710 9_c01 9283_c1co p66431_c0
m 119236_c4co p72789_c011 319_c0comp 1773116455_c0co p 37 9m 110988_c1
co p 779 3119024_c0comp 6767118031_c3co p 1623 0m 108014_cco p 172 0 0
1 4811_ccomp 02609 0118762_cco p 4548 0m 108061_cco p 19693 010 60_c
comp 13937 31 1478_c2co p 17187 0m 1 4055_cco p 06711 011888 _ccomp 376 1
117098_c0co p36180_c0m 119286_c1co p2030 _c0112841_c0comp 200111176_c0
co p98995_c0m 740co p114597_c03 73 _c0comp106114_c096490_c0co p 884
m 110070_c0co p 09992 11 5571_c0comp95395_c08272co p119657_c0m 8080
co p1078 6_c01920 1comp72636_c098887co p117669_c0m 924co p118698_c0
7 3 1comp11 999_c094 0 1co p118582_c0m 0233co p118484_c009566
−2 0 2
Value
Color Key
Figure 2.7: Differential Expression of control vs. cut animals. Green shows relatively increased
expression, red shows relatively decreased expression.
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Figure 2.8: Differential Expression of control vs. cut animals. RNA-seq datasets show discrimination between different treatments.
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Figure 2.9: Differential Expression of cut (no serotonin) vs. cut (serotonin) animals. Green
shows relatively increased expression, red shows relatively decreased expression.
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Figure 2.10: Differential Expression of cut (no serotonin) vs. cut (serotonin) animals. RNA-seq datasets show discrimination between different
treatments.
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  1       10        20        30        40         50       
Dtig_m.24616            LE  N      L   F  A             ADFD   Y I N   DK     S  L   R V EV LQK  KAGNK EKI L    AI K N   N I L I.. YF G K TA I KQC G EK. I Y C
Hsap_NP_690601.1        LE  N      L   F  A             ADFD   Y I N   DK     S  MIL   RIIEE  A K N AGNK E VE T     VL H S P   TKVMV IVN T L E A P A V F G NG S
Sman_Smp_010690         LE  N      L   F  A             ADFD   Y I N   DK     S  MII   RAVEEI VTR Q K SR DKID TV    IV  S P   KILV IVC E EE Y Y S T NN K F
Emul_000305600.1..pep    LE  N      L   F  A             ADFD   Y I N   DK     S  MI    AVEDL LTR N KAG K EKID TV    VL R  P   SKLLV LF FH S S F F Y R H EG L
 60        70        80        90       100       110       
Dtig_m.24616           F   L        L R YG            V    DL   P            LKRNLK FK  E AD V K E  L S PG N TI F  L D E LAH A L    Q Q YD K DR C PPE C Q TK D I E N A
Hsap_NP_690601.1       F   L        L R YG            V    DL   P            LKRNLK YKE AD L K   FL N G N SL Y  L D IVH A M    QAHG E V S V P.ES Y L EN ASK S Q G
Sman_Smp_010690        F   L        L R YG            V    DL   P            LKRNIK FHE E V V  E  FL S P S TL   L D LAH L    K HG NE A D S AE. NQ CI EK S HNQ KCG
Emul_000305600.1..pep   F   L        L R YG            V    DL   P            LKRNV  F E E VE L R E  YI PG S TL F  V D E VAR V M    N D K YD G A LDEPY Y C QN E C V H A
120       130          140       150       160       170    
Dtig_m.24616         C A VFE  F  Q           A I Y  DE MYV    DR TV FST FKD DD  I F    F Y    RD  T   AM   V  I   V     II S T D ESGNIAK...Q T N K E S
Hsap_NP_690601.1     C A VFE  F  Q           A I Y  DE MYV    DR TV FST FKD DD  I F    Y F R V H RD  T     V  V   V     VV S K Q EEGKEGEN.. ESKK D
Sman_Smp_010690      C A VFE  F  Q           A I Y  DE MYV    DR TV FST FKD DD  I     F Y R V H RD  T   AL   V  I        LL M A K E IKSNADSGSK Q A T P
Emul_000305600.1..pep C A VFE  F  Q           A I Y  DE MYV    DR TV FST FKD DD  I F    F  R V H      AL   I  I   V     VV A P LL ALADEPIISK SP A Q E A
   180       190       200       210       220       230    
Dtig_m.24616         GK F QE  E RR    APQVL S   PP EL  T A       YITFVLF RH     A  V I  T A  R DR     Y KE  I  K   AVGENVA          L V P G K N FATPA
Hsap_NP_690601.1     GK F QE  E RR    APQVL S   PP EL  T A       YITFVLF RH     A  V M  F         F HRE  L  K  D AVGDNI        P   K G ASHT D G TN.AS
Sman_Smp_010690      GK F QE  E RR    APQVL S   PP EL  T A       YITFVLF RH     A  V M  FT V  R DR     Y HR      D VI DSVA       P   L V K QG S LSTES
Emul_000305600.1..pep GK F QE  E RR    APQVL S   PP EL  T A       YITFVLF RH     A  I M  FT V  R DR     Y HRE  A  R  D V GDN A       P   Y D G R LAPHA
   240       250       260       270       280              
Dtig_m.24616             I LI T R YLHYHIKC K     RMRAK   F K L RA                R NS   H  N        S A I M     S  L L   KP EIK D F H H GN K ............
Hsap_NP_690601.1         I LI T R YLHYHIKC K     RMRAK   F K L RA                R NT   H          S AYI      T D L V N  RP DAD N F D HT S ............
Sman_Smp_010690          I LI T R YLHYHIKC K     RMRAK   F K L RA                R ST     N        S AYM M     T E L V N  H IN D Q L Q V ..............
Emul_000305600.1..pep     I LI T R YLHYHIKC K     RMRAK   F K L RA                S    H  N         YL L     T E I I N  P DDR . N V A G Q S V HQQQQQQQQQLN G
     290              300       310       320               
Dtig_m.24616                                                        T            S V L S GR SA GSGCEAVDFRG TD.......LGIEGLN G GDSLSQKKTFT FLPQS.......
Hsap_NP_690601.1                                                    T            E GK SKK....................................EMKTIT FS R........
Sman_Smp_010690                                                     T            E S V I S GR TH TNTVINTNITT SGEVAPISPLMNKIGG Q DN........M MR G........
Emul_000305600.1..pep                                                T            E S L L S P  QE AEPAVFVHALG ESSRSQIHRQPANRRG A GNAFSSENMLM S LS SDFACLQKF
                                                            
Dtig_m.24616         ................................                            
Hsap_NP_690601.1     ................................                            
Sman_Smp_010690      ................................                            
Emul_000305600.1..pep EDSEDEREEEEDGVLSAPLMANSIPPSPCFDA                            
 
Figure 2.11: Flatworm-Human target homology. Sequence alignment ARPC2. Each D. tigrina
target sequence was aligned against its nearest S. mansoni, E. multilocularis, and human homolog.
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    1       10        20             30        40        50 
Sman_Smp_069770                         L               LF HR T  NN    F F  MALRT L R S RN S     E E  T  E S.... FGSVSLKL C SDG F F.....GRQ SH V R SN P A
Dtig_m.6038                             L               LF HR T  NN    F F  M RN I R Q R S     D D  T  E N..... F F....YQN Y G.I K .......RCL DK T P AN L S
Emul_001114700                          L               LF HR T  NN    F F  L I N L S T S     D    E T..MG N A QCFWSLRM SASKV LN LPLKAFRSF TA W AI RDVL P
Hsap_NP_066552.2                         L               LF HR T  NN    F F  AALR R N KT     D E  T  D TMFFS ARAAGLTAHWG HVR H VMQ...NGAGGA V P PD P P
       60        70        80        90       100       110 
Sman_Smp_069770 EN  R       YP         P LD AQRQ GWLPISAM K AE L  P MRV EVAT  K LD I SN  HKAAAII A  L            N V  I V    Y    K V I PA H N Q
Dtig_m.6038     EN  R       YP         P LD AQRQ GWLPISAM K AE L  P MRV EVAT  K IE I SN  GH AALI V  L            N V  I M    Y    L T K D QN H D R
Emul_001114700  EN  R       YP         P LD AQRQ GWLPISAM K AE L  P MRV EVAT  R LE L T   G HA LIM A  I            S I   V    F    L E K H V Y S N Y G E
Hsap_NP_066552.2 EN  R       YP         P LD AQRQ GWLPISAM K AE L  P MRV EVAT  K IE I N  GHKAAAVL V  L            N V  V V    Y    Y A VK E N Q P
      120       130       140       150       160       170 
Sman_Smp_069770 FYTM NR PVG YH Q CT  PC L    S  IL    K LGI  G TT DK FT   VE    F     K  I I  TT  M GGVG EV  L        P  M  LTE  E NA K N EP Q
Dtig_m.6038     FYTM NR PVG YH Q CT  PC L    S  IL    K LGI  G TT DK FT   VE    F     R  V L  S  I GGVG DI  E I     K  E    L  LSE  D C T K H P S
Emul_001114700  FYTM NR PVG YH Q CT  PC L    S  IL    K LGI  G TT DK FT   VE    F     K  V L  TT  M GGVG DV  E I     K  E  P  L  IS   N T E T T Q
Hsap_NP_066552.2 FYTM NR PVG YH Q CT  PC L    S  IL    K LGI  G TT DK FT   VE    Y     K  I V  TT  M  D   E I     K  E  P  L  L E  K R..N S A Q K V I
      180       190       200       210       220       230 
Sman_Smp_069770 CLGACVNAPM   ND YYEDLT  D   I    KA K PK GP SG   R   EP G  T          MQI  D      AE IR L EI  G K  P  Q  Q  FA   K GL T E GG S
Dtig_m.6038     CLGACVNAPM   ND YYEDLT  D   I    KA K PK GP SG   R   EP G  T          M V  D      VD VR L D    R  P  Q  Q  FAC  K L A T N F N SN K
Emul_001114700  CLGACVNAPM   ND YYEDLT  D   I    KA K PK GP SG   R   EP G  T          MQI  D      D VR L DL  G K    Q  Q  AC  K G  P V S H GH C F
Hsap_NP_066552.2 CLGACVNAPM   ND YYEDLT  D   I    KA K PK GP SG   R   EP G  T          VQI        A   I EL  G   P     F C   GL N K IEE D I R ... S A
      240                                                   
Sman_Smp_069770 SL   P  P F     L                                             N  K  G KV  TE S RSD ......
Dtig_m.6038     SL   P  P F     L                                             T  KG G KV  EE RSD ......
Emul_001114700  SL   P  P F     L                                             N  P  KL  TP V D QDA KYTVDI
Hsap_NP_066552.2 SL   P  P F     L                                             T  KG G V  EP G QAG ......
 
Figure 2.12: Flatworm-Human target homology. Sequence alignment SDH1. Each D. tigrina target
sequence was aligned against its nearest S. mansoni, E. multilocularis, and human homolog.
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 1       10        20        30             40        50    
Emul_000422600                                                        Y   DHT A PT R STV  TII  .MEKPPNCQFSC FM FLVRASFASFAARLG.....CL FAGAS HV GKD
Sman_Smp_061230                                                       Y   DHM HLA S AI N S K R S  TII  ...... V L LN RKATKLNYLT ........IYQ F ..C NL YT.SG
Dtig_m.21611                                                          Y   DHM RLL N V S PT R TQI  TIV  ...... S C LKR YEFSGKKVGI R........F R ..LLSS SKD
Hsap_NP_004159.2                                                       Y   DHL RLL LA T GN R K SI  VV  MSGVRG S SARR LAKAWPTVLQ GTRGFHFTVD K ASA VSD SAQ P
    60        70        80        90       100       110    
Emul_000422600    DAVVVGAGGAGLRA FGL   GF TA  TKLFPTRSHTVAAQGGINAALGNME D W TY              A   AN   K  CV                           KE Q H
Sman_Smp_061230   DAVVVGAGGAGLRA FGL   GF TA  TKLFPTRSHTVAAQGGINAALGNME D W SF                 AN   K  I                           RG E I P D
Dtig_m.21611      DAVVVGAGGAGLRA FGL   GF TA  TKLFPTRSHTVAAQGGINAALGNME D W TY              A   AN   K  CI                           RS K D
Hsap_NP_004159.2   DAVVVGAGGAGLRA FGL   GF TA  TKLFPTRSHTVAAQGGINAALGNME D W F              A       CV                           RE SEA N E N
   120       130       140       150       160       170    
Emul_000422600   H  DTVKGSDWLGDQDAIHYM E AP  V ELENYG PFSR   G IYQRAFGGQ    F MF                  C E  KA I      M    LEN K         SL YH
Sman_Smp_061230  H  DTVKGSDWLGDQDAIHYM E AP  V ELENYG PFSR   G IYQRAFGGQ    F MY                  C E  KA I      V    LEN K         SI YD
Dtig_m.21611     H  DTVKGSDWLGDQDAIHYM E AP  V ELENYG PFSR   G IYQRAFGGQ    Y MY                  C E  K  I      M    LDN          I YT M A D
Hsap_NP_004159.2  H  DTVKGSDWLGDQDAIHYM E AP  V ELENYG PFSR   G IYQRAFGGQ    W Y                     A V      M    E  K         SL FF T Q A T D K
   180       190       200       210       220       230    
Emul_000422600  G GGQAHRCC VADRTGHSLLHTLYGRSL Y   YF EYF  DLLME G CRG  A   E K                          R ET   I   AL     N    I  MCL A D V N
Sman_Smp_061230 G GGQAHRCC VADRTGHSLLHTLYGRSL Y   YF EYF  DLLME G CRG  A   E R                          R D   I   VL     N E   VI VCL A AT
Dtig_m.21611    G GGQAHRCC VADRTGHSLLHTLYGRSL Y   YF EYF  DLLME G CRG  A   E K                          K DT   I   AM      E   VL L L C D H N
Hsap_NP_004159.2 G GGQAHRCC VADRTGHSLLHTLYGRSL Y   YF EYF  DLLME G CRG  A   E K                          R DT   V   AL     N E   VI LCI C S
   240       250       260       270       280       290    
Emul_000422600  DG  HR R KNT  ATGGYGR  FSCTSAHT TGDGTAM  RAGLP  D EF QFHPTGI  TI  F A   IL       Y        C       VT     N  M  V       A E
Sman_Smp_061230 DG  HR R KNT  ATGGYGR  FSCTSAHT TGDGTAM  RAGLP  D EF QFHPTGI  TL  F    VL       TY        C       VT     N  M  V       S Q
Dtig_m.21611    DG  HR R KNT  ATGGYGR  FSCTSAHT TGDGTAM  RAGLP  D EF QFHPTGI  TL  F A   VL       TF        C       IS     N  M  I       E
Hsap_NP_004159.2 DG  HR R KNT  ATGGYGR  FSCTSAHT TGDGTAM  RAGLP  D EF QFHPTGI  SI   A   VV       TY               IT      L  V       I S CQ
   300       310       320       330       340       350    
Emul_000422600  YGAGCLITEGCRGEGG LINS GERFMERYAP AKDLASRDVVSR MT EIREGRG GP                 Y                            I       V  E N A R
Sman_Smp_061230 YGAGCLITEGCRGEGG LINS GERFMERYAP AKDLASRDVVSR MT EIREGRG GP                 Y                            I       V  K N A R
Dtig_m.21611    YGAGCLITEGCRGEGG LINS GERFMERYAP AKDLASRDVVSR MT EIREGRG GP                 Y                            I       V  E K S Q
Hsap_NP_004159.2 YGAGCLITEGCRGEGG LINS GERFMERYAP AKDLASRDVVSR MT EIREGRG GP                                             L         I Q V S C E
   360       370       380       390       400       410    
Emul_000422600  KDH  L L HLP   L  RLPGISETA IFAGVDVT  P PVLPTVHYNMGG PTNYKGQ   Y     D  KS                 KE V            V       C K H P L E
Sman_Smp_061230 KDH  L L HLP   L  RLPGISETA IFAGVDVT  P PVLPTVHYNMGG PTNYKGQ   IF Q    D  HS                 RD I            I       S A Q K
Dtig_m.21611    KDH  L L HLP   L  RLPGISETA IFAGVDVT  P PVLPTVHYNMGG PTNYKGQ   IF Q    E  K                  RD I            I       S M L H M
Hsap_NP_004159.2 KDH  L L HLP   L  RLPGISETA IFAGVDVT  P PVLPTVHYNMGG PTNYKGQ   VY Q    E  T                 KE I            I       H P Q A M
   420       430       440       450       460       470    
Emul_000422600  V              GLYA GE A  SVHGANRLGANSLLD VVFGRACAL I     PG I YD AT KDKIIP    A  V CA               L          AE K  T A G D KC
Sman_Smp_061230 V              GLYA GE A  SVHGANRLGANSLLD VVFGRACAL I     PG L YD V K KVVP    A  A A               I          A K  A P AK G S D AKN
Dtig_m.21611    V              GLYA GE A  SVHGANRLGANSLLD VVFGRACAL I     PG I YD T KDKIV     A  A C                I          AE K  D PH K K T T EN
Hsap_NP_004159.2 V              GLYA GE A  SVHGANRLGANSLLD VVFGRACAL I     PG L VN D IVP      A CA               L          E R  RH.. GQ Q C S E SC
   480       490       500       510       520       530    
Emul_000422600     P      G  S  N  K R   G       RL MQ   Q  AAVFR G  L  G  KD  ELHP   VA ID L  Q DV    RTM EH     D PV   FG ET ME SGK FPVS E KA VE
Sman_Smp_061230    P      G  S  N  K R   G       RL MQ   Q  AAVFR G  L  G  KD  ELKP  E  IA E L A  S V    RTM E      D P   C  AG DT A Y T N YPIAQ D Y T KE K
Dtig_m.21611       P      G  S  N  K R   G       RL MQ   Q  AAVFR G  L  G  KE  DL  E  IA LD V A  S EI    KT  EH     D PV  C  KQ SKNA Q H N LSTA K N QA K
Hsap_NP_004159.2    P      G  S  N  K R   G       RL MQ   Q  AAVFR G  L  G  KD  IKP  E  VM LD L A  S EL    KSM H      V  C  KV P NA E F D IRTS S N V S QE G
   540       550       560       570       580       590    
Emul_000422600      Y      LK  D    WN DL E LELQNL     QTI  AE RKESRGAH RED M L   VS KSLI  S  I       LINAV     A        A   FLK AAKYDN G VA
Sman_Smp_061230     Y      LK  D    WN DL E LELQNL     QTI  AE RKESRGAH RED M L M   VS RS I  S  M       MLNAL   G  A        A   FYD ASR ND K A V
Dtig_m.21611        Y      LK  D    WN DL E LELQNL     QTI  AE RKESRGAH RED I I M   LS RSMI  S  V       MIN L   G             FLD RND QQ A S Y N S
Hsap_NP_004159.2     Y      LK  D    WN DL E LELQNL     QTI  AE RKESRGAH RED I L L    R MV  T  V       ML AL   G  A        A   YSK G.D KH TF G T C Y
Figure 2.13: Flatworm-Human target homology. Sequence alignment NDUFV2. Each D. tigrina
target sequence was aligned against its nearest S. mansoni, E. multilocularis, and human homolog.
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Figure 2.14: Semi-quantitative RT-PCR of RNAi experiments. Images of representative semi-
quantitative RT-PCR gels. The first four non-ladder lanes are RNAi worms and the last two lanes are
negative controls. The bottom bands are 18S Ribosomal RNA reference reference (300 bp), and the top
bands are ARPC2 amplicons (600 bp).
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Figure 2.15: Semi-quantitative RT-PCR of RNAi experiments. Images of representative semi-
quantitative RT-PCR gels. The first four non-ladder lanes are RNAi worms and the last two lanes are
negative controls. The bottom bands are 18S Ribosomal RNA reference reference (300 bp), and the top
bands are NDUFV2 amplicons (600 bp).
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CHAPTER 3. PLATYHELMINTH-SPECIFIC RHODOPSIN-LIKE
ORPHAN FAMILY: FAMILY EXPANSION, PHYLOGENY, AND
IMPLICATIONS FOR DRUG TARGETING
A paper submitted, awaiting publication of seminal 50HGI manuscript
Nicolas J Wheeler1,2,3 Mostafa Zamanian4, Prince N Agbedanu1, Michael J Kimber1, Dennis
Lavrov5, Nancy Holyrod6, Matthew Berriman5, Tim A Day1,2,7
3.1 Abstract
G-protein coupled receptors, especially neuropeptide receptors, have been shown to be ab-
solutely critical in platyhelminth biology and are the source of ongoing study as potential drug
targets in parasitic flatworms. However, the high conservation of GPCRs between parasites
and human hosts can complicate such inferences, as any chemical targeted to GPCRs is likely
to cause host toxicity. It is hypothesized that this effect could be abrogated by focusing on
phylum-specific proteins, paying particular attention to orphan proteins. Here, we describe
the expansion of the recently discovered Platyhelminth-specific Rhodopsin-like Orphan Family
to 25 flatworms, many of which have had genomes recently published via the 50 Helminth
Genomes Initiative. These genomes were passed through the Compara comparative genomic
pipeline, assigning each predicted gene to a conserved family. A combinatorial approach utiliz-
ing phylogenetics and Hidden Markov Models distinguished four PROF Compara families from
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4Department of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA
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the more then 200 GPCR families. A total of 238 predicted protein models were validated
as PROFs, making it the largest clade of Class A (Rhodopsin-like) receptors. Additionally,
the phylogeny Class A receptors shows the PROFs to be strongly related and most closely
related to established neuropeptide receptors. This family is shown to be one of the largest
phylum-specific families, contain three paraphyletic subfamilies, and have robust expression in
the neurogenic tissue of juvenile and adult worms.
3.2 Introduction
Nearly 500 million people living in developing countries are parasitized by platyhelminths,
causing upwards of 100,000 deaths per year and the loss of millions of healthy life-years. Four
types of platyhelminthiases schistosomiasis (Schistosoma), foodborne trematodiases (Clonorchis,
Opisthochis, Fasciola, Paragonimus), echinococcossis (Echinococcus), and taeniasis/cysticer-
cosis (Taenia) have been designated by the World Health Organization (WHO) as neglected
tropical diseases (NTDs) and subsequently emphasized in current and future research. Further-
more, infections in animals and livestock primarily trematodiases are equally significant and
add to the burden experienced by developing countries, particularly in rural farming communi-
ties. While these diseases have often been conceptualized as diseases of only developing regions,
cases of schistosomiasis have been reported in Europe [21], and climate change is hypothesized
to further increase the incidence of flatworm infections across the European Union [31], further
affirming the urgent need for additional NTD research.
In recent years, the WHO has initiated preventive chemotherapy in some endemic coun-
tries. In 2014, over 49 million at-risk children were treated with praziquantel, the efficacious
anthelmintic used mainly for the prevention and control of schistosomiasis, and this number will
continue to rise ][228] . The other drug of choice, triclabendazole, is used for control of food-
borne trematodiases. Unfortunately, the combination of the large burden and the widespread
preventive efforts leads to the fear of drug resistance, which has been demonstrated in the
laboratory [60] and reported in the field [71, 91].
New anthelmintics need to be developed and added to the repertoire of chemotherapeutics
for the neglected platyhelminthiases. We and others have proposed the utilization of free-living
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flatworms as a platform to identify, predict, and screen putative drug targets [36, 37, 44, 224].
The bottleneck for such a pipeline was the absence of necessary sequence information for both
free-living and parasitic flatworms. Recent sequencing projects [165, 187, 214] have widened
this bottleneck, and the path is clear for a new emphasis on identifying pan-phyletic drug
molecules.
G protein-coupled receptors (GPCRs) are the mostly widely drugged protein class, targeted
for all types of diseases, and their extreme functional and evolutionary diversity theoretically al-
lows for specific targeting. Although traditionally perceived only as precise modulators, GPCRs
in flatworms have been shown to be essential to proper motility, a key factor in successful par-
asitism [52, 53, 130, 159]. However, their general similarity to human receptors raises concern
that toxicity would accompany drug targeting.
There has been renewed focus on orphan genes, or taxonomically restricted gene families
that have no computationally identifiable annotation (Fang et al., 2015; Tang et al., 2012). So
motivated, we have used bioinformatics to search for platyhelminth-specific gene families. Re-
cently, comparative genomics and transcriptomics within a subset of the flatworms (Schmidtea
(free-living), Girardia (free-living), Schistosoma (fluke), and Echinococcus (tapeworm)) uncov-
ered a large family of GPCRs that showed no readily identifiable similarity to non-flatworm
organisms [224, 236]. This Platyhelminth-specific Rhodopsin-like Orphan Family (PROF) was
designated as a Class A GPCR subfamily and showed some similarity to other flatworm neu-
ropeptide GPCRs. Other than these initial clues, no other functional information has been
gleaned about these receptors.
At the time of their discovery, the PROFs appear to be greatly diverged from any mam-
malian or vertebrate ancestor, allowing the possibility of designing or discovering molecules
that are selective, and even specific, for the parasite receptor family. However, only a hand-
ful of flatworms had sequenced genomes at this time, so the taxonomical-restriction of the
PROFs could not be definitively determined. With the recent availability of over two dozen
flatworm genomes and comparative genomic resources to classify phylum-specific gene families,
we sought to search for PROFs in these new organisms. We have expanded the PROF family
by identifying the PROFs in all flatworm genomic sources included in Sangers 50 Helminth
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Genomes Initiative, which incorporated 25 different flatworms (unpublished, but available at
www.parasite.wormbase.org). Additionally, we have inferred a comprehensive phylogeny to
provide evolutionary information regarding distinctions between the three PROF subfamilies
and fit the PROF within the scope of Class A GPCR evolution. Finally, we have conglomerated
available life-cycle expression data from parasites and demonstrated neurogenic tissue-specific
expression in free-living flatworms. We foresee these data providing invaluable information to
aid and support deorphanization efforts and functional characterization, and the conclusions
herein demanding further study as potential drug targets.
3.3 Results
3.3.1 PROF Gene Identification and Family Expansion
Our coarse GPCR analysis identified 200 putative GPCR gene families. We set three filters
to parse putative PROF families from these 200 GPCR families. Each family was 1) Class A
(Rhodopsin-like), 2) absent in taxa outside of the flatworms, and 3) had no readily identifiable,
computationally-derived annotation. Importantly, in addition to dozens of nematodes and
flatworms, several diverse animal outgroups, notably Crassotrea gigas, a mollusk and the most
closely related outgroup to the Platyhelminthes, were included in the Compara family analysis.
Four families survived filtering and were hypothesized to be PROFs. These families included
284 genes (238 with at least 5 and less than 8 transmembrane domains) with representatives
from each of the 25 flatworms included in the analysis, making the PROF one of the largest
clades of flatworm Class A GPCRs (unpublished data from 50HGI). The two largest PROFs
contained at least one representative from each species included and are two of the top five
largest phylum-specific families, further emphasizing the likely importance of these receptors
to the biology of flatworms. The other two PROFs included representatives from each of the
Trematoda and assorted others from Cestoda, Monogenea, and Turbellaria.
Species of the class Trematoda had on average more PROF genes per organism than the
other flatworm classes (Table 3.1), and blood flukes (Schistosoma and Trichobilharzia) had
substantially more than the liver or intestinal flukes (Clonorchis, Fasciola, and Echinostoma).
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While both Monogenea (Protopolystoma xenopodis) and Turbellaria (S. mediterranea) only
had one representative species, making statistically significant inference difficult, they each
had fewer PROFs than the average Trematoda, but more than the average Cestoda. These
findings corroborate the discovery of widespread GPCR family loss in Cestoda after splitting
from Trematoda [214].
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Table 3.1: Statistics of putative PROF subfamilies. PROF1 is the largest subfamily due to an
expansion in trematodes. PROF3b was likely lost in cestodes. In general, trematodes have more PROF
genes than cestodes, mimicking the pattern for the GPCR superfamily as a whole.
Species Phylum family 272753 family 302163 family 804503 family 1051524 Total
PROF1 PROF2 PROF3a PROF3b
Diphyllobothrium latum Cestoda 2 4 1 0 7
Echinococcus granulosus Cestoda 1 3 1 0 5
Echinococcus multilocularis Cestoda 1 4 1 0 6
Hydatigera taeniaeformis Cestoda 1 4 1 0 6
Hymenolepis diminuta Cestoda 1 4 1 0 6
Hymenolepis microstoma Cestoda 1 2 1 0 4
Hymenolepis nana Cestoda 1 4 1 0 6
Mesocestoides corti Cestoda 1 3 1 0 5
Schistocephalus solidus Cestoda 2 4 1 0 7
Spirometra erinaceieuropaei Cestoda 1 6 3 0 10
Taenia asiatica Cestoda 1 4 1 0 6
Taenia solium Cestoda 1 4 1 0 6
Protopolystoma xenopodis Monogenea 1 3 2 1 7
Clonorchis sinensis Trematoda 3 5 2 1 11
Echinostoma caproni Trematoda 3 6 2 1 12
Fasciola hepatica Trematoda 1 5 1 1 8
Schistosoma curassoni Trematoda 11 6 2 1 20
Schistosoma haematobium Trematoda 10 6 2 1 19
Schistosoma japonicum Trematoda 9 5 2 1 17
Schistosoma mansoni Trematoda 10 4 2 1 17
Schistosoma margrebowiei Trematoda 12 6 2 1 21
Schistosoma mattheei Trematoda 10 6 2 1 19
Schistosoma rodhaini Trematoda 9 6 2 1 18
Trichobilharzia regenti Trematoda 22 5 2 1 30
Schmidtea mediterranea Turbellaria 5 5 0 1 11
TOTAL 120 114 37 13 284
Upon the initial discovery of the PROF, 66 genes were identified in S. mediterranea and
S. mansoni, but only 21 of these were linked to predicted gene models; the remainder were
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manually found in the genomic sequence contigs [236]. Our analysis here was able to add 1 and
10 more putative PROF gene models to the S. mediterranea and S. mansoni complements,
respectively, substantiating this approach, its power in identifying PROFs in other flatworms,
and the value of using comparative approaches to review previous annotations of older genomes.
3.3.2 Phylogenetics
We used molecular phylogenetics to place these genes within the greater Class A of Rhodopsin-
like GPCRs (Figure 3.1). As a model, we chose the receptors of S. mansoni, as they are the
most completely annotated and contain the most nearly complete gene models. As expected,
the 4 putative PROF subfamilies were found to form one monophyletic clade, paraphyletic with
other Class A peptide receptors. We note that it appears that these orphan receptors are most
closely related to neuropeptide receptors.
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Figure 3.1: Phylogeny of S. mansoni Class A GPCRs. PROFs are monophyletic and share a
common ancestor with neuropeptide and hormone receptors.
Next, the PROF phylogeny was constructed (Figure 3.2). Two separate runs, each with 4
chains, satisfied all relevant measures of convergence after 20,000,000 generations. The eight
reversible-jump Metropolis-coupled Markov chains Monte Carlo calculated poster probabilities
from the sampling frequency to compare each of 9 fixed rate protein substitution matrices
to find the most suitable model. Interestingly, both runs predominantly sampled from the
Cprev model, which was created from plastid genomes [4], as it routinely provided the highest
likelihood score. Wary of this result, we reran the analysis with a model created from the
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transmembrane domains of Class A GPCRs [174] and also attempted to estimate from the data
a variable rate general time reversible model. However, neither of these performed better than
the Cprev model, raising questions about the suitability of the most widespread models, which
typically use orthologous sequences from model organisms and tend to be biased with vertebrate
sequences, for flatworm data. However, we found that the reversible-jump algorithm had higher
sampling rates for suitable and intuitive models when dealing with full-length globular proteins
from flatworms (data not shown), suggesting that our result with transmembrane sequence may
be specific to our dataset.
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Figure 3.2: Complete phylogeny PROFs. Four Compara families (gray boxes) are classified into 3
PROF subfamilies. Cartoon-ized clades contain only genes from species of that particular flatworm class. In
general, Turbellaria genes are basal to parasitic genes, following the species tree. Ectoparasitic Monogenea
tend to be basal to the endoparasitic Trematoda and Cestoda, but sometimes cluster with Cestoda. These
inconsistencies parallel the difficulty of confidently inferring the phylogeny of flatworms at the class level.
Regardless, the two runs were able to recapitulate each of the 4 families that were clustered
by the Compara pipeline (Figure 3.2). Most of the nodes of this tree are highly supported
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by the posterior probability (mean = 92) Notably, the least supported are those nodes that
join different Compara families (bounded by gray boxes) and those joining genes from differing
flatworm classes (red, blue, purple, and orange leaves). An exception, though, is the node that
joins the two smallest families. This node has a posterior probability of 100%, indicating that
these two families are probably a part of a larger individual gene family. Interestingly, when
combined, this larger family contains one representative from each of the flatworms, mimicking
the pattern of the other Compara families.
The convergence of the runs, along with the high support of the tree at-large, especially
nodes within Compara-deduced families, compels us to hypothesize that these PROFs are
actually three separate subfamilies, related by their common grouping into Class A (Rhodopsin-
like) GPCRs. While it is tempting to infer that each family is activated by a separate ligand,
only functional deorphanization and pharmacologic profiling can give such information. This
conclusion is consistent with previous study of PROF phylogeny within S. mansoni and S.
mediterranea [236]. Thus, we dub Compara Family 272753 as PROF1, Family 302163 as
PROF2, and Families 804503 and 1051524 as PROF3a and PROF3b, respectively.
3.3.3 Expression Analyses
S. mediterranea was used as a model to analyze tissue expression of one PROF2 represen-
tative. Figure 3.3 shows robust mRNA expression in a ’tuning-fork’ pattern along the cerebral
ganglion and longitudinal nerve cords of the planarian nervous system. This pattern establishes
PROF2 as an endoGPCR and is not activated by an exogenous chemical like chemosensory
GPCRs. This is a significant discovery, as two recent bioinformatic GPCR surveys, using ne-
matode chemoreceptors as bait, have annotated PROF receptors as chemosensory, calling into
question the reliability of these annotations. [109, 184].
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Figure 3.3: Relative expression of PROF complements in two parasitic flatworms. S. mansoni
(left) and F. hepatica (right) demonstrate the general pattern of increased expression during juvenile life
stages. NOTE: relative expressions should not be compared between organisms.
We also used available life stage-specific expression data from the trematodes S. mansoni
and F. hepatica to create expression profiles for each of the PROF genes. While the plots (Fig-
ure 3.4) show some variability among the receptors, the general pattern of increased expression
in the juvenile stages is immediately conspicuous. DESeq leveraged biological replicates to
estimate the effective library size for each life stage, allowing stage-to-stage comparison and
ensuring that this pattern is not simply due to differences in read depth or stage transcrip-
tional activity. This pattern is notable, as one of the few flaws of praziquantel is its lack of
efficacy against the juvenile stage (schistosomula) of schistosomes. Thus, it is desired that
the next-generation of antischistosomals are effective in treating both juvenile and adult worm
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stages.
Figure 3.4: In situ hybridization of one PROF2 representative. (Left) The localization of a single
PROF2 transcript is shown along the longitudinal nerve chords (red) and the cerebral ganglion (green)
of Schmidtea mediterranea. (Right) The planarian head region reveals PROF2 expression in the cerebral
ganglion (green).
3.4 Conclusion
We present here a comprehensive assemblage of all available data for the Platyhelminth-
specific Rhodopsin-like Orphan Family. We have annotated a total of 284 protein coding genes
in 25 flatworm organisms. We find that these genes are ubiquitous in all four Platyhelminth
classes analyzed, suggesting importance to the phylum as a whole, and we note its expansion
in Trematoda. We have established a high-confidence phylogeny for these genes and show that
each of the three subfamilies is broadly conserved across the phylum and appeared early in
flatworm speciation. Within S. mansoni, the PROF subfamilies are monophyletic within Class
A (Rhodopsin-like) GPCRs, and they are most closely related to neuropeptide receptors. In
situ hybridization in a free-living representative shows tissue-specific neurogenic expression. In
two parasitic flukes, we show a pattern of increased expression in juvenile stages and adult
stages, life stages that correspond to parasitism of humans.
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Recently, two studies have used clustering, phylogenetics and a BLAST strategy to func-
tionally annotate flatworm GPCRs [109, 184]. Both of these studies annotate PROF receptors
as chemosensory receptors because of their apparent relatedness to nematode chemoreceptors.
While the data presented here provides evidence that the PROFs may be neuropeptide recep-
tors, and the tissue expression of one PROF2 representative implicates it as an endoGPCR,
we are careful to show restraint in ascribing annotation without any supporting functional
data. It may be that other PROF receptors are expressed in the tissue periphery and used
in chemoreception. Flatworms certainly engage in complex chemosensation and, in effect, be-
havioral adaptation in accordance with sensitive and precise environmental cues. However,
no chemosensory GPCR has yet been deorphanized in this phylum, and those presumptive
chemoreceptors that flatworms do express are unlikely to be orthologous to the known nema-
tode chemoreceptors.
Indeed, it is believed that diverse clades of 7 transmembrane-containing chemosensory recep-
tors from vertebrates (olfactory, trace amine-associated, vomeronasal type 1 and 2, taste type 1
and 2), insects (olfactory, gustatory), and nematodes (19 separate families, including srw) arose
independently after their respective ancestors evolved into land-dwelling organisms [15, 141],
though insects and nematodes may still share one class of gustatory receptors [181]. Given
that flatworms share no common land-dwelling ancestor with vertebrates, arthropods, and ne-
matodes, it is unlikely that a flatworm chemoreceptor would be truly orthologous to chemore-
ceptors from these popular models. It is thus inappropriate to use chemoreceptor sequences
from these diverse models as bait to search for or annotate flatworm chemoreceptors, and it is
misleading to force flatworm sequences into a chemoreceptor phylogeny that does not include
equal representation from all taxa involved in the analysis. Finally, the PROFs are scattered
throughout the genome (Table 3.2) and do not mimic the genomic architecture of C. elegans
chemoreceptors, which are all found clustered together on chromosome 5 [180]. Evolutionary
information and life-history data such as these must be taken into account when attempting
to annotate newly discovered (or newly sequenced) genes and genomes.
It has been hypothesized and supported in other taxonomies that orphan genes can be
correlated with neofunctionalization [230], often in morphological or biochemical aspects, so
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it is possible that the PROF receptors are involved in something particularly novel to the
flatworm lineage. Furthermore, orphan GPCRs are the target of intense study in humans for
their possible therapeutic exploitation [61, 202, 206]. The restriction of these receptors to
flatworms and their expression in parasitic stages compels further interest in elucidation of
their endogenous ligand(s), their biological function, and their study as drug targets.
3.5 Methods
3.5.1 Sequence Data
All predicted proteomes were acquired from Wormbase ParaSite. SRA files from the most
recent Fasciola hepatica and Schistosoma mansoni transcriptomes (PRJNA179522 and PR-
JEA36577 [165]) were downloaded from the NCBI. Gene families inferred by the Compara
pipeline were obtained from Matthew Berriman and Nancy Holyrod of the Wellcome Trust
Sanger Institute.
3.5.2 GPCR Identification
Lists of seed sequences were populated by assembling known or predicted GPCR sequences
from free-living and parasitic flatworms and nematodes. For the nematodes specifically, there
was heavy reliance upon GO annotation and prediction. Sequences from Schmidtea mediter-
ranea, S. mansoni, Caenorhabditis elegans, Onchocerca volvulus, and Brugia malayi were uti-
lized for this initial list. While the analysis here deals specifically with platyhelminths, ne-
matode sequences were included so that the full complement of helminth GPCRs could be
identified from the data provided by the Sanger Institute. These seed accessions were then
used to parse the Compara gene families provided, pulling out each family (and the accessions
therein) that included at least one seed. Compara families contained a range of platyhelminth,
nematode, and outgroup genes. An in-house Python script utilized these accessions to scroll
through each helminths genome file and create FASTA files for each individual family.
Because most of the seed genes were uncurated, or at least had not yet been experimentally
validated, and the putative GPCRs initially numbered over 10,000, we undertook a family-
59
based approach to supporting these genes as bona fide GPCRs. Family FASTA files were
first aligned with MAFFT [99] (mafft --auto family_number.fasta > family_number.aln). Next,
alignments were automatically trimmed to their most conserved sequence domains - likely
the transmembrane regions [137] - with trimAL [35] (trimal -automated1 -in family_number.aln
-out family_number.trim.aln). HH-suite 2.0 was used to build a Hidden Markov Model (HMM)
for each family (hhmake -i family_number.trim.aln -M -50) and search it (hhsearch -i
family_number.hmm -d ~/hhsuite-2.0.16/database) against clustered data-bases of HMMs from Pfam
[62], SCOP [10], PDB [17], and UniProt. These databases were built using differing method-
ologies (see the HH-suite documentation), so use of each one ensured that GPCR identification
was not overly dependent upon one database, especially one that prioritized mammalian se-
quences. The most significant hit from each of these databases were gathered, and each family
was assigned a value (1-4) for GPCR support. Families that had GPCR hits for at least two
of the databases were kept. Additionally, GPCRDB [89] class designation (Classes A, B, C
and F) was assigned and validated for each family by randomly BLASTing 2-5 representative
sequences against the NCBIs non-redundant translated nucleotide sequence database.
3.5.3 PROF Designation
Of the confirmed GPCR families, PROFs were nominated by (1) containing only platy-
helminth sequences, (2) being Class A (Rhodopsin-like), and (3) being orphan receptors. Or-
phan status was confirmed by BLASTing 2-5 representative sequences against the NCBIs non-
redundant translated nucleotide sequence database; these were most similar to either previously
curated PROF genes or contained no consensus annotation within the significant hits (e-value
1e03).
3.5.4 Phylogenetics
We maintained the tradition of only using transmembrane sequences as phylogenetically
informative [218]. Each GPCR or putative PROF sequence was trimmed to its transmembrane
domains by identifying the domains with HMMTOP [215] and trimming it with an in-house Perl
script. These trimmed sequences were aligned with MAFFT and subjected to Bayesian phy-
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logenetic inference with MrBayes 3.2 [182]. Two reversible-jump Metropolis-coupled Markov
Chain Monte Carlo (MCMC) runs, each with 4 chains sampling every 1000 generations, were
run in parallel on the CyStorm high-performance computing system for 20,000,000 genera-
tions. The MCMC also sampled among all possible fixed-rate amino acid evolutionary models
and used a gamma rate distribution with some invariable states (prset aamodelpr=mixed; lset
rates=invgamma).
3.5.5 Expression Profiles
RNA-Seq reads were re-mapped to the most recent S. mansoni and F. hepatica genome and
annotations available on WormBase ParaSite (BioProjects: PRJEA36577 and PRJNA179522;
Assemblies: ASM23792v2 and F hepatica 1.0.allpaths .pg; Genebuild version: 2014-05-WormBase).
TopHat [213] was used to map RNA-Seq reads to these genomes, and featureCounts [124] was
used to count the raw reads mapped to each gene. The R package of DESeq [8] was used to
normalize count data and ggplot2 [229] was used to create line graphs for these data.
3.5.6 In situ Hybridization
Receptor gene fragments were PCR amplified with the minimal T7 polymerase promoter
sequence appended to the 5 anti-sense primer. Digoxigenin-labeled antisense riboprobes were
synthesized using these PCR products (Roche). Whole-mount in situ hybridization (WISH)
was performed at 55C in hybridization solution (50% formamide, 5XSSC, 100 ug/ml yeast
tRNA, 100 ug/ml heparin sodium salt, 0.1% Tween-20, 10 mM DTT, 10% dextran sulfate
sodium salt). DIG-labeled riboprobe (40 ng/ml) was denatured at 72C for 15 min immediately
prior to hybridization. BCIP/NBT was used for chromogenic color development, followed by
paraformaldehyde fixation and imaging.
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3.6 Additional Materials
Table 3.2: Genomic features of S. mansoni PROFs. Like most S. mansoni genes, the majority of
the PROFs have a single exon. Unlike C. elegans chemoreceptors, PROFs are scattered throughout the
genome; they are found on chromosomes 1, 3, 4, ZW and several unplaced scaffolds. The gene model for
Smp 196080 is likely a fusion between a PROF receptor and a myosin protein.
Gene Family Locus Exons
Smp 157050 family 1051524 Smp.SC 0313:39018-40310 2
Smp 084270 family 272753 Smp.SC 0677:2067-3176 1
Smp 091950 family 272753 Smp.Chr 3:21985382-21986482 1
Smp 167870 family 272753 Smp.SC 0111:252547-253623 1
Smp 177720 family 272753 Smp.Chr 3.unplaced.SC 0044:1913109-1914230 1
Smp 203400 family 272753 Smp.Chr ZW:8222368-8223480 1
Smp 204060 family 272753 Smp.Chr ZW:8409798-8410985 1
Smp 204550 family 272753 Smp.SC 0111:258383-259477 1
Smp 083950 family 272753 Smp.Chr 3.unplaced.SC 0044:1964528-1965808 2
Smp 083940 family 272753 Smp.Chr 3.unplaced.SC 0044:1934639-1963395 3
Smp 196080 family 272753 Smp.Chr 3:21988262-22007247 8
Smp 041880 family 302163 Smp.Chr 4:21927065-21928093 1
Smp 117340 family 302163 Smp.Chr 3:21718117-21719394 1
Smp 001070 family 302163 Smp.Chr 1:64165239-64230896 2
Smp 023710 family 302163 Smp.Chr 3:21772171-21773439 2
Smp 170620 family 804503 Smp.Chr 1:58945336-58948044 1
Smp 170610 family 804503 Smp.Chr 1:58871918-58873276 2
62
CHAPTER 4. A CASE FOR THE CAREFUL FUNCTIONAL
ANNOTATION OF GPCRS IN PARASITIC WORMS
A paper to be submitted
Nicolas J Wheeler1,2,3 Michael J Kimber1, Mostafa Zamanian4, Tim A Day1,25
4.1 Introduction
Parasitic worms of the phyla Nematoda and Platyhelminthes infect over one billion hu-
mans and devastate agricultural plants and livestock. The arrival of the genomic age and
the subsequent sequencing of dozens of parasitic worm genomes have reinvigorated hope that
target-based drug discovery may initiate a wave of next-generation anthelmintic development.
The rapid expansion of parasitic worm sequence data has largely outpaced our ability to
make sense of the data. Reliable functional annotation of this abundance of newly discovered
genes presents some significant challenges [73], and while misannotation has long been an is-
sue [198, 25], it is exacerbated when new sequences are from the less studied phyla and branches
of the tree of life. In these cases, experimental biologists are coerced to rely on progressively
less informative data to make decisions and declarations about functional annotations of genes.
This is hardly catastrophic; for the most part many genes can be accurately annotated with a
reasonable degree of surety based on sequence homology, signature motifs, and the conservation
of key functional domains.
Several tools make preliminary predictions of gene function by using similarity-driven al-
1Department of Biomedical Sciences, Iowa State University, Ames, IA USA
2Interdepartmental Genetics and Genomics, Iowa State University, Ames, IA USA
3Primary author
4Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI USA
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gorithms that compare new sequences to accessions in curated databases. These approaches
have limitations [96], especially for parasitic worms. A need for caution is compelled by the
vast evolutionary distance between the phyla housing parasitic worms and the large bulk of
well-characterized proteins at disposal for comparisons. While there are a significant number of
functionally characterized proteins from organisms nearly related to parasitic nematodes, there
are far fewer sources for platyhelminth parasites. In both cases, though, parasitologists are
often obliged to shoehorn invertebrate data into mammalian or vertebrate annotation schema.
Concerns about the accuracy of sequence-based preliminary annotations are more pro-
nounced with G protein-coupled receptors (GPCRs). Sequence-based comparisons do not reli-
ably predict the ligands that will activate GPCRs, or the downstream signaling systems that
they will activate, or the host of other important functional characteristics that are often the
primary points of inquiry. These kinds of functional classifications are very difficult to parse
in vivo, especially in many of the least tractable parasites, so preliminary predictions based
solely on primary sequence data are often accepted. Here, we describe the confounding na-
ture of these biologically important, potentially vulnerable parasite proteins, and we suggest a
cautious, more holistic approach to thinking about their functional annotation.
4.2 Parasitic Worm GPCRs
Parasitic worm GPCR complements cohere reasonably well with either of the major classi-
fication systems that have emerged in attempts to make sense of the GPCR superfamily.
• Attwood and Findlay [14] and Kolakowsk [105] used transmembrane sequence patterns
to classify or fingerprint GPCRs into groups labelled A-F. This system is incorporated
by GPCRDB [90] and has been used to describe GPCRs in a parasitic worm [33].
• Schith and Fredriksson inferred the phylogeny of human GPCRs and showed that they
segregate into five families that they labelled GRAFS. They also demonstrated the suit-
ability of this system for other animals, vertebrates and invertebrates alike [63]. We
and others have also used this system to classify the complements of parasitic worm
GPCRs [236, 214].
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Classification of parasitic worm GPCRs into the large A-F or GRAFS families is relatively
simple, and automated pipelines do so accurately. However, these two systems depart from each
other significantly when it comes to sub-family categorization, and automated approaches can
become unreliable at this level. These sub-family categories attempt to align with functional
characteristics, such as the specific ligands that activate the GPCRs in a certain sub-family,
so it is notable that they are confounding for parasitic worm GPCR contingents. For example,
the Rhodopsin-like group (the largest class of parasitic worm GPCRs) includes receptors that
respond to a wide range of ligands, ranging from photons to peptides, making ligand prediction
an arduous task. In contrast, Glutamate-like and Frizzled-like receptors respond to a much
more limited spectrum of ligands [239, 88, 205]. Thus, for the majority of parasitic worm
GPCRs, classification is only broadly useful and does not aid in precise functional annotation
that is desired.
4.3 The Challenge
The enterprise of confidently annotating GPCRs in silico is complicated by three distinct
qualities. First, outside the 7 canonical transmembrane (TM) regions, GPCRs contain very few
definitive functional domains. Those that are known to be present are found in a subset of re-
ceptors in the non-Rhodopsin groups, which comprise a small fraction of worm GPCRs [236, 33].
Second, the Rhodopsin-like GPCRs have diverse and diffuse ligand-binding domains. For small
ligands in particular, most of their cognate receptors binding residues are in the core of the
transmembrane regions and dispersed throughout [111]. Even if ligand binding residues of a
receptor are known, it is challenging to extrapolate these interactions to homologous recep-
tors [133]. Third, while phylogenetics can place a novel GPCR upon an evolutionary backdrop,
a complete phylogeny does not differentiate between gene duplications that have lead to neo- or
sub-functionalization, and it cannot capture the idiosyncratic differences that may distinguish
between receptors of similar sequence but divergent functional traits. The TM domains and
the ligand-binding residues therein experience unique selection pressures [200], which should
be accounted for when making evolutionary assumptions of functional relatedness. This likely
contributes to the observation that divergent receptors showing little sequence similarity can
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respond to the same ligand and, contrastingly, homologous receptors with high similarity can
respond to different ligands [125].
The convoluted and opaque evolutionary history of the GPCR superfamily further impedes
functional annotation via phylogenetics. Phylogenetic techniques assume that the sequences
included are homologous. Whether or not the main families of GPCRs are descended from a
single common ancestor is still a question, though recent evidence suggests that the Rhodopsin-
like, Frizzled-like, Glutamate-like, and Adhesion-like families descended from a 7 TM gene in
a eukaryotic common ancestor [108]. Nevertheless, convergent evolution of GPCRs is also
widespread [54, 82, 156, 116, 122]. These complications - the ancient genesis of the superfam-
ily, the lack of sequence-similarity between GPCR families, and reports of GPCR convergent
evolution - can cause GPCR phylogenies to be misinferred and can impede functional annota-
tion from them.
In an attempt to circumvent these issues, one might capitalize upon newer, innovative
analyses that use similarity-driven clustering in multidimensional space [160, 92, 185]. These
approaches are not as constrained by models of molecular evolution and can be preferable when
dealing with large protein families, sets of gene models that have differing levels of confidence,
or datasets with non-homologous genes. Parasitic worm GPCRs have these characteristics, but
because of the confounding sequence traits described above, more granular inferences - those
focused on protein function - can be spurious. This is particularly important when dealing with
highly diverged GPCRs or datasets that include a diverse range of species.
Both phylogenetic and clustering approaches have the potential to produce inconsistent
inferences about receptor function. For example, a large grouping of flatworm receptors
(Platyhelminth-specific Rhodopsin-like Orphan Family; PROF) was initially discovered and
annotated, using a phylogenetic approach, as a Rhodopsin family outgroup [236] with the hy-
pothesis that they may be neuropeptide-responsive. Since then, gene models for Schistosoma
mansoni have been improved with RNA-Seq [165], and a more sensitive Bayesian inference
supports the original topology (Figure 1). In contrast, recent reports have annotated members
of this receptor grouping as chemoreceptors based on sequence similarity to the nematode srw
family of chemoreceptors [185, 109].
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In the absence of experimental data, neither in silico approach is sufficient for confidently
annotating the function of these receptors. The evolution of volatile compound chemosensation
occurred quickly after the migration of water dwelling animals to the land. This functional
adaptation happened independently in ancestors of nematodes and arthropods [15], after the
split between Lophotrochozoa (flatworms) and Ecdysozoa (nematodes). Thus, even if the PROF
and srw clades have an ancient relation, it is unsuitable, based on the phylogeny or sequence-
similarity alone, to transfer organismal function from one to the other. Whether these receptors
have true chemosensory or neuropeptidergic (or other) function remains to be seen, but the
PROF case study demonstrates how diverse methodology can lead to incompatible inferences,
and, critically, how molecular and pharmacologic experiments are necessary for true functional
annotation of parasitic worm GPCRs.
4.4 Difficult and Important Cases
Most of what is known about GPCRs comes from experimentation in mammalian systems.
When a parasitic worm GPCR is closely related to a mammalian receptor, similarity methods
may be able to inform functional annotation. However, for many receptors from these less-
studied taxa, reliance upon mammalian comparisons is less dependable. We will consider two
types of GPCRs as examples to illustrate this weakness.
4.4.1 Taxonomically-Restricted GPCRs
As more nematode and flatworm genomes are sequenced, researchers are able to use compar-
ative genomics to identify phylum, clade, class, or life-style specificity that may confer import
traits involved in host-parasite interactions [112]. This is new frontier for parasitologists, as
previous work has only been able postulate as to the specificity of gene families of interest. We
are now able to confidently ascribe taxonomic-restriction, and we predict that taxonomically-
restricted gene families will be and should be of great interest in the future, especially with
GPCRs.
A recent comparative analysis of parasitic worm GPCRs found that over 60 of the 200 GPCR
families identified are constrained to worms and were not found in any outgroups including
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humans, zebrafish, oysters, flies, and others. Furthermore, at time of writing, the current
release of WormBase ParaSite [85] (Version: WBPS7) contains 11,315 protein-coding genes with
predicted GPCR activity (GO:0004930) in worms without an orthologue in flies, human, mouse,
budding yeast, or zebrafish. These taxonomically-restricted receptors are of great interest and
ought to receive increasing attention, but similarity-based analyses provide no clear direction
to inform functional annotation, especially for the platyhelminth receptors.
4.4.2 Orphan GPCRs
Many of these taxonomically-restricted GPCRs are orphans. Like taxonomically-restricted
GPCRs, functional annotation of orphans is also troublesome, and they are too often broadly
and conclusively annotated in literature or databases without any molecular, biochemical, or
pharmacologic evidence. As described, primary sequence can enable classification of these
orphan receptors, but it is mostly impotent when seeking to draw more decisive and sensitive
conclusions. In these cases, one is left directionless.
Few worm receptors have been definitively deorphanized in vivo – that is, few have been
demonstrably paired with an endogenous ligand. In general, the first GPCRs in parasitic
worms to be pharmacologically deorphanized are those for which measures of sequence simi-
larity provide high-likelihood hypotheses that point to a particular ligand. As these conserved
GPCRs continue to be cloned and profiled, the divergent, orphan GPCRs will remain, for which
sequence similarity provides little direction. In C. elegans, there is evidence that the prelimi-
nary predictions by sequence similarity fail and mislead ligand identification [135], and this is
likely to be true for more divergent orphans in parasitic worms as well. Indeed, the sequence
databases allude toward this result. For instance, genes from 26 flatworms in ParaSite Worm-
Base are annotated as dro/myosuppressin receptors. Myosuppresin, a peptide ligand, has never
been described or isolated in either nematodes or flatworms, and this annotation comes from
the extrapolation of work performed in fruit flies. Ancylostoma duodenale and Romanomer-
mis culicivorax, two parasitic nematodes, also have Putative dro/myosuppressin receptors, and
these annotations are inferred by orthology to a S. mansoni protein. This annotation had made
vast evolutionary leaps from Arthropoda to Platyhelminthes, and from Platyhelminthes to Ne-
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matoda. Such examples are ubiquitous across the functional annotations of parasitic worm
genomes. Of course, most know to be wary of unsupervised automated annotating pipelines,
but these examples manifest the impropriety of using the underlying logic - sequence similar-
ity - to annotate parasitic worm GPCRs. Preliminary annotations can be useful indeed, but
caution has to be taken when evaluating the predicted ligands of orphans.
4.4.3 Related Difficulties
These examples are not to suggest that in silico studies are worthless. Rather, studies
of GPCR similarity, relatedness, homology, and putative function are all important, but the
conclusions of each are not always correlated, and we need to avoid drawing bold arrows from
one to the other. That is, homologous receptors are not always obviously similar, and receptors
that are obviously similar do not always share a common function [197]. When in silico studies
are undertaken, it is important that the bounds and limitations of each approach are made
clear and that restraint is shown in their conclusions.
Computational identification and preliminary annotation should be supplemented with ex-
perimentation that probes the expanse of different GPCR characteristics. This work is difficult
but necessary in order to fully appreciate the purpose and function of parasitic worm GPCRs
and their possible exploitation in chemotherapy. Below, we briefly describe five main attributes
and associated caveats to be considered when seeking to a newly identified parasitic worm
GPCR.
4.4.3.1 Identification of ligand(s)
A GPCRs ligand is arguably the most important piece of functional data that can be
determined, and much of the GPCR literature deals with receptor deorphanization, the process
of pairing receptors with ligands. There are several caveats that should be considered in this
endeavor. For example, there are examples of ligand-independent and constitutive GPCR
signaling [167] that potentially extend to parasitic worms [130]. GPCRs can also form homo-
and heteromeric complexes [196, 203], making identification and delineation of the endogenous
ligands non-trivial. For peptidergic receptors, receptor promiscuity is likely widespread in
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parasitic worms [138], and in vitro sensitivity to a molecule may not correlate with ligand
responsivity in the native environment [150]. Despite these warnings, the vast majority of
GPCRs have at least one ligand of biological relevance, and receptor deorphanization should
be one of the first aims when annotating a newly identified GPCR.
4.4.3.2 Spatial expression
Knowledge of the spatial distribution of receptor expression can provide clues about receptor
signaling and physiology. Animals dictate GPCR expression patterns with cellular [23, 78] and
subcellular specificity [42], and receptors are likely to be expressed in the same tissues or in
proximity to the signals they receive. For instance, GPCRs in chemosensory organs or cell types
are likely to be chemoreceptors [23, 51] and GPCRs at the neural-muscle interface may receive
one of the many known chemical signals that are involved in muscle control [159]. Learning the
cells, tissues, and organs in which GPCRs are expressed can aid interpretation of native and
in vitro GPCR function, as well as the appraisal of specific GPCRs as parasite drug targets.
4.4.3.3 Temporal expression
It is also essential to know the parasite life stages in which GPCRs are expressed and ac-
cessible to potential ligands. In terms of therapeutic potential, it is necessary that the targeted
receptor be expressed in the intra-host life stages amenable to pharmacologic intervention [134].
Expression data can include both transcript and protein abundances, but they are not neces-
sarily linked. Measuring transcript levels at certain points in time does not indicate that the
receptor is being translated or trafficked to the membrane. Receptor internalization, turnover,
and recycling must be considerations when drawing inferences from these expression data.
4.4.3.4 Downstream signaling pathways
Canonical GPCR signaling progresses through activation of the Gα subunit, but it is now
clear that there are a variety of signaling cascades. Typically, the C-terminus of the receptor
directly interacts with one of a number of different Gαs, leading to a specific downstream
result. Alternative signaling through Gβγ was demonstrated early on[128], and other non-
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G protein mediated routes have been discovered, particularly through β-arrestin [119]. For
parasitic worms, less is known about the repertoire of G proteins and their function, although
their structure largely resembles that of mammalian G proteins.
4.4.3.5 Phenotype
Understanding the biological functions mediated by these GPCRs is usually the ultimate
goal. Those biological functions are generally probed by the association of particular pheno-
types with GPCR loss of function. However, in parasites there are limitations in the available
genetic tools, and it is difficult to relate the few, limited phenotypes available in the laboratory
to the breadth of biological functions that are important to parasites throughout their complex
life-cycle. For example, one needs to be especially wary of RNAi phenotypes, as some believe
that many behavioral phenotypes, especially a decrease in general motility of whole organisms,
could be due to general sickness rather than acute inhibition of a single transcript [68, 103].
Availability of a only a few, limited phenotypes can induce us to ascribe unwarranted impor-
tance to any detected function, often to the exclusion of other possible functions for which
we simply have no phenotypic probe. Nonetheless, when properly employed, RNAi can be
a powerful annotation tool and can reveal relevant biological functions. As the experimental
toolkit advances, it will be helpful to be able to create knockdowns, or even knockouts, in
specific tissues or cell-types, and progress would be greatly facilitated by the development of
more relevant phenotypic assays in parasitic worms [235].
4.5 Conclusion
There are a variety of approaches to gather this information, but these annotations have
only been studied in a limited number of GPCRs in helminths (Table 4.1). Classification of
receptors of the non-Rhodopsin groups (Glutamate, Adhesion, Secretin, and Frizzled) will also
inform some of the other canonical GPCR attributes. However, for the Rhodopsin-like family
of parasitic worm GPCRs, classification, sequence-similarity, and homology can give clues to-
ward some functional attributes, but alone these threads are insufficient and will provide an
incomplete, and even misleading, picture. Unfortunately, there is momentum in the literature
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to turn many of these clues into hard and fast functional annotations, and, as demonstrated,
these annotations have waterfall effects when provided to pipelines that continually annotate
new genomes.
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Table 4.1: Summary of all experimental results studying GPCRs of parasitic worms.
Deorphanization
Name Species Ligand Cell Type In Vitro G protein coupling Reporter of GPCR Activity Localization Stage of Confirmed Expression RNAi Phenotype
SmGPR-1 [77] Schistosoma mansoni Histamine HEK293, COS7 Native G proteins Ca2+ accumulation Cercaria, higher in young juveniles,
adults
SmGPR-2 [57] S. mansoni Histamine Saccharomyces cerevisiae strain YEX108 Chimeric Gαq Growth Nervous system; subtegumental neuronal
plexus of adult and larvae
Cercaria, higher in young juveniles,
adults
SmGPR-3 [58] S. mansoni Dopamine S. cerevisiae strain YEX108 Chimeric Gαq Growth Nervous system; main nerve cords and the
peripheral innervation of the body wall
muscles
SmGAR-1 [130] S. mansoni Acetylcholine S. cerevisiae strain Cy13393 Chimeric Gαi Growth Hypoactive larvae
Sm5HTR [159] S. mansoni Serotonin HEK293 Native G proteins cAMP stimulation Nervous system, including the cerebral
ganglia and main nerve cords and the pe-
ripheral innervation of the body wall mus-
cles and tegument
Hypoactive juveniles and adults
SmGluR [205] S. mansoni Glutamate HEK293 Native G proteins cAMP stimulation Longitudinal nerve cords and cerebral
commissures; peripheral nerve fibers and
plexuses innervating the acetabulum and
the somatic musculature; length of the fe-
male reproductive system
Cercaria, higher in young juveniles,
adults
SmD2 [204] S. mansoni Dopamine HEK293, S. cerevisiae strain Cy13393 Native G proteins, Chimeric Gαs cAMP stimulation Subtegumental somatic musculature and
acetabulum of all larval stages tested; en-
riched in the somatic muscles of adults and
the muscular lining of the caecum
AsGAR-1 [102] Ascaris suum Acetylcholine S. cerevisiae strain YEX108 Chimeric Gαq Growth Head and tail
As5HTR2 [87] A. suum Serotonin, LSD COS7, HEK293 Native G proteins Radioligand binding; PI turnover Pharynx and body wall muscle
GpFLP-32 [13] Globodera pallida Increase in migration rate
BmNPR-4 [9] Brugia malayi FLP-18 family HEK293 Native Gαi proteins cAMP attenuation
Bm4 [194] B. malayi Tyramine, LSD HEK293 Native G proteins Radioligand binding
Hc110-R [186, 139] Haemonchus contortus α-latrotoxin (LTX), AF1, AF10,
PF2; PF1022A and emodepside (an-
tagonists)
HEK293 Native G proteins Ca2+ accumulation
Hc5HTR1 [195] H. contortus Serotonin Sf9, AV12-Ga15 Promiscuous Gα15 Radioligand binding; Ca
2+ accumulation L1/L2/L3, adult
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The preponderance of the tools leveraged to functionally annotate parasitic worm GPCRs
rely upon sequence similarity to known receptors. Unfortunately, it is becoming clear that
the resulting inferences are not as extensible as once was hoped. Outside of similarity-driven
analyses, other comparative in silico approaches that make use of genomic synteny will be
more useful for annotation as parasitic worm genomes progress closer to chromosome-level
assemblies [7]. Until then, given the current difficulties, we suggest that parasitologists commit
to a more precise experimental toolset for studying and annotating GPCRs. This may seem
prosaic, but it will be worthwhile to take time to sensitively functionally annotate individual
receptors rather than add to the already overwhelming dataset of GPCRs of unknown function.
Collaboration and teamwork is key, and a commitment by the parasitology community to
caution and rigor will have important outcomes on the continuing functional annotation of
diverse parasite genomes.
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CHAPTER 5. SUMMARY AND DISCUSSION
There are four conceptual trajectories toward anthelmintic discovery and development (Ta-
ble 1.1). The high cost of screening infected animals (Trajectory #1) limits its applicability,
which has demanded the innovation of new techniques that will also produce improved under-
standing of flatworm biology.
Here, we generated a de novo transcriptome for a species of planaria, Dugesia tigrina. This
transcriptome will prove to be a valuable resource for the basic study of planarian and flat-
worm biology as well as more translational approaches that are oriented toward anthelmintic
discovery. As a proof of this claim, the transcriptome was used in a comparative analysis that
innovated a new pipeline to prioritize putative drug targets that are shared within the flatworm
phylum. By comparing the D. tigrina transcripts to genes from a blood fluke Schistosoma man-
soni and a tapeworm Echinococcus multilocularis, filters were constructed to remove unshared
genes and genes that are unlikely to be worthy of further study as targets. Putative targets
that survived these filters were then compared to human genes, with the working hypothesis
that toxicity in humans could be avoided by choosing targets not conserved in the host. Of
course, there are some drugs for infectious diseases that do not support this hypothesis - the
benizimadizoles being a prime example (see chapter 1). Nevertheless, comparison to host genes
remains a popular filter in other subtractive and comparative genomic approaches [55, 207].
After a set of putative targets conserved amongst flatworms were pooled, several experi-
ments were performed to demonstrate that phenotypes caused by pharmacologic inhibition or
transcript knock-down in planaria were reproducible in schistosomes. Pharmacologic inhibi-
tion of the actin binding complex (ARP2/3) resulted in reduced motility in both planaria and
schistosomes (Figure 2.5A), and gene specific knock-down in planaria impaired regenerative
capacity and resulted in eventual death (Figure 2.6B). The chemical used to inhibit ARP2/3,
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CK-666, is commercially available and unlikely to be a good lead because its inhibiting action is
efficacious in all sorts of organisms [147, 175]. Instead, these experiments serve to demonstrate
how debilitating phenotypes in planaria are often reproduced in schistosomes. The contrast
was shown to be true as well for the shared protein NADH dehydrogenase. The NADH dehy-
drogenase inhibitor rotenone showed no effect on either planaria or schistosomes (Figure 2.5C),
and knock-down of NADH dehydrogenase also showed no phenotype (Figure 2.6A).
Thus, chapter 2 contributed to two separate anthelmintic discovery trajectories (Figure 5.1).
It demonstrated the utility of D. tigrina as a platyhelminth model for in vivo screens, and it
demonstrated a method for putative drug target prioritization using genetic comparisons. This
work also showed how both trajectories can provide valuable biological conclusions. As stated,
the D. tigrina transcriptome is a valuable resource in and of itself, not only for potential discov-
ery of novel anthelmintics; its comparison to other flatworm or metazoan sequences could also
be useful in evolution and ecology, toxicology, regeneration, and other sorts of studies. In addi-
tion, the RNAi and pharmacologic inhibition experiments for ARPC2 and SDH1 (Figure 2.5B)
provided insight into the biological functions of these two proteins.
Chapter 2
Dugesia tigrina
ARP2/3 (and other putative targets)
Trajectory #3
in vivo RNAi/chemical screen of model
Trajectory #4
Chemical Screen of Heterologously Expressed Target
Lead compound and biological conclusions
Lead compound
Figure 5.1: Objectives of Chapter 2. Chapter 2 demonstrates how focus on anthelmintic development
can lead to translational lead compounds as well as biological conclusions.
Systematic RNAi screens are already underway in the planaria Schmidtea mediterranea,
with particular focus given to regeneration [179, 221]. D. tigrina could be an added resource in
this pursuit, one that could possibly enable a higher throughput because of their more reliable
hardiness in lab cultures. Diversifying the species of planaria used in screens could also provide
hits that would have been otherwise missed when using only S. mediterranea. Finally, these
screens ought not solely be performed with focus given to stem cells and regeneration, but
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phenotypes that are classically associated with anthelmintic mechanisms should be considered
as well, such as membrane depolarization, motility, death, or neural dysfunction [39, 37].
Reducing the size of container needed for screening, allowing for increased throughput,
would be a helpful development for this platform. In the assays described here, planaria were
individually observed in 35 mm Petri dishes, with a maximum of 6 dishes per experiment. This
is a far too large container for screening with any sort of throughput. It is unlikely that the
high-throughput phenotyping machinery used for screening C. elegans will ever be matched for
planaria, but work could be performed to adapt planaria culture techniques that are amenable
for 96 well plates. Immmortalizing a planarian cell line has not yet been accomplished, but
an individual worm can be cut into hundreds of pieces that could be sorted into plates [142].
New robotic cell imaging and computer vision approaches could track tissue regeneration and
survival, looking for similar effects to that seen in ARPC2 RNAi experiments (Figure 2.6C).
In an alternative to the unbiased filtering and pooling of potentially druggable proteins, one
can identify potential proteins for trajectory 4 by hand-selecting superfamilies that are known
to be druggable. We emphasize G protein-coupled receptors in this approach because of their
proven druggability in other systems [152]. As plasma membrane receptors, GPCRs are easily
accessed by small molecule chemicals, and GPCRs have many critical biological functions in
platyhelminths. Indeed, emodepside, a drug used to treat gastrointestinal nematode parasites,
was originally shown to have latrophilin, a Class B GPCR, as its target [186, 79]. However,
further experiments implicated a potassium channel, SLO-1, as the more important target [75].
The differing pathways and their cross-talk are still being worked out, but it is clear that
attenuation of latrophilin signaling is an important part of emodepside’s activity. Outside of
this one anecdote, no other GPCR is targeted by marketed anthelmintics.
It is often misconceived that GPCRs act solely as modulators in platyhelminths, with actions
too slow to be a good drug target. This is often contrasted with fast acting ion channels, and
it is argued that this is the reason that ion channels are the targets of the vast majority
of marketed anthelmintics. However, GPCRs have important neuromuscular roles, and their
activation can have immediate and strong effect on these systems [159, 53, 52]. Even so, it
is unclear why GPCRs have yet to be confirmed as an anthelmintic target when they seem
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so suitable for other types of chemotherapeutics. Because each of the anthelmintics to target
ion channels (pyrantel, derquantel, levamisole, ivermectin, monepantel, and emodepside, for
example) were discovered through screens of infected animals, it is possible that these screens
are not equipped to identify other types of targets. If so, new approaches may validate GPCRs
and other proteins as true anthelmintic targets.
In a collaboration with the parasite genomics group at the Wellcome Trust Sanger Institute,
a census was taken for the GPCRs of 81 different flatworms and nematodes, including many par-
asites (Appendix A), and the GPCR complement of each organism was compared (Figure A.1).
The constructed heatmap allows for comparisons between clades, classes, species, and phyla,
and it reveals a number of interesting patterns. The Platyhelminth-Specific Rhodopsin-Like
Orphan Family (PROF, see chapter 3) was striking in this analysis. When first identified in
Schmidtea mediterranea and Schistosoma mansoni, it was hypothesized to be a putative drug
target that deserved further analysis on the basis that it 1) was a GPCR, 2) was a large (and
therefore important) clade of GPCRs within these two flatworms, 3) phylogenetically clustered
with putative neuropeptide receptors, and 3) showed evidence of being taxonomically-restricted
to the flatworms. However, at the time, it was inconclusive if this lineage of GPCRs was ex-
panded in all flatworms, if it indeed had neuropeptidergic capacity, and if it was actually
phylum-specific.
The sequencing of 25 flatworm genomes in the 50HGI allowed for a broader analysis of the
PROF (chapter 3). Through this analysis, it was shown that the PROF is actually the largest
subfamily of GPCRs found in platyhelminths. In fact, the PROF is the largest phylum-specific
gene family overall. It was also confirmed that the PROF is indeed expanded throughout the
phylum (Table 3.1) and that one of its members is expressed in neural tissue (Figure 3.4).
Moreover, publicly available stage-specific RNA-seq datasets show that many PROF members
are highly expressed in the juvenile stages of Fasciola hepatica and S. mansoni, and some are
expressed throughout the life cycle (Figure 3.3).
After all this, can we now confirm that PROF receptors are good candidates for heterologous
expression and screening? Unfortunately, the fact remains that the ligands of any of the PROF
receptors are still unknown. Because of this, there would be no positive control for PROF
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expression in heterologous systems, which would make it impossible to find small molecule in-
hibitors for a PROF. This brings up an important note. Although screening of heterologously
expressed targets will not provide new information regarding the biological function of targets
within the worm (Table 1.2), the only targets that ought to be moved through this trajectory
are those for which a good deal of biology is already known. For a receptor, knowledge of the
endogenous ligand is necessary to validate it as a screening candidate. Though comparative
genomics and filtering pipelines can highlight proteins that may be druggable, these targets
are not good candidates for heterologous expression and screening unless their function is con-
firmed. In this tangential way, trajectory 4 can also further our understanding of basic flatworm
biology (Figure 5.2). For the majority of flatworm proteins that do not have well studied or-
thologs, precise experimental functional annotation must be performed before embarking on
mechanistic-based screening protocols. This is of immeasurable importance to the success of
the screen, but it also provides important, novel understanding of flatworm biology.
Chapter 3
PROFs
Trajectory #4
Chemical Screen of Heterologously Expressed Target
Lead compound
Chapter 4
Functional 
annotation
Biological conclusions
Figure 5.2: Objectives of Chapters 3 and 4. Chapters 3 and 4 demonstrate how focus on anthelmintic
development can lead to translational lead compounds as well as biological conclusions.
Unfortunately, functional annotation of new platyhelminth genes tends to be imprecise,
especially for GPCRs (chapter 4). For the most confounding (and most interesting) GPCRs,
those that are taxonomically-restricted, automatic annotations performed in silico are essen-
tially empty. From both basic and applied research perspectives, it is absolutely critical to be
confident in the functional annotations that are provided in literature and online databases. For
this reason, chapter 4 called for a recommitment to careful functional annotation of GPCRs,
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especially those that are good drug targets. Care and caution in functional annotation will be
crucial not only for the development of new anthelmintics, but for the wholistic understanding
of the biology of flatworms. This same care needs to be given to the PROF receptors before
they are screened for anthelmintics.
A recommitment to a more nuanced approach to the functional annotation of GPCRs should
hearken back to the thrust of chapter 2. Parasite GPCRs are difficult to study; parasites
themselves are intractable to transgenesis, difficult and costly to culture, and they have few
phenotypic assays by which to probe protein function. These difficulties are exasperated for
GPCRs that are taxonomically-restricted to the flatworms, like the PROFs. The obvious
answer to this conundrum is to use the planarian model to study these receptors.
RNAi in planaria is straightforward and cheap, and knock-down experiments have short
turnaround times. As mentioned, there are many more phenotypic assays available for planaria
than parasitic flatworms, making it more likely that a knock-down experiment would give
positive results. A comprehensive RNAi screen of planaria GPCRs would be a reasonable next
step for this work.
For aminergic receptors, this approach would undoubtedly provide a wealth of information
regarding their function. There are still multiple monoamines that are synthesized in flatworms
that have yet to be linked to their cognate receptor; tyramine and octopamine are the most
prominent of these orphan ligands. Deorphanization of these could be accomplished by es-
tablishing phenotypes for exogenous tyramine or octopamine treatment, and then attempting
to ablate that phenotype by iterative RNAi knock-down of the hypothesized receptors. This
approach has been used for a planarian serotonin receptor, but it has yet to be leveraged for
any other flatworm GPCR [234]. After confirmation in planaria, these experiments could then
be repeated in parasitic flatworms, using the sequence of the confirmed planaria receptor to
point to the likely homolog in the parasite.
However, for PROF receptors and the other putative neuropeptide receptors, it is possible
that redundancy could mask any RNAi phenotypes. Some neuropeptides are believed to have
pleiotropic effects in these systems [5], and the expansion and high sequence conservation among
the PROF receptors hints toward this redundancy. This could be potentially confounding for
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RNAi screens, and it could cause false negatives for the previously described deorphanization
approach by ”rescuing” an ablation phenotype through functional redundancy. In this case,
degenerate dsRNA constructs could act to knock-down several PROF receptors at once, but
a high dose of dsRNA and a buildup of digested nucleotides may result in toxicity that would
give a falsely positive result. Thus, knock-down approaches are unlikely to be informative for
the PROF and other putative neuropeptide receptors. In cases such as these, the planarian
model may fall short.
Heterologous expression of GPCRs and screening with potential endogenous ligands (instead
of potential anthelmintics) is the best way to match ligands and receptors. This is difficult in
cell line expression systems like yeast, insect, or mammalian cells, because flatworm receptors
often run into problems with proper folding, membrane trafficking, or signal transduction. For
these experiments, there is no positive control, and it is time consuming and expensive to
confirm membrane expression by raising antibodies against the receptor. Expression vectors
could be designed with tags, but it is possible that a GFP or His tag, for instance, would
interfere with wild type ligand recognition or downstream signaling. If a first-pass screen fails
to provide any hits, the logical next step is unclear. In a departure from traditional heterologous
expression in cell lines, perhaps there are other more suitable systems. Mammalian receptors
have been expressed in a tissue-specific manner in C. elegans [209, 188], and parasitic nematode
GPCRs have been screened in this way [117]. It is possible that this system would be amenable
for flatworm receptors as well. Further, with the advent of precise genome editing tools like
CRISPR-Cas9 [47], potentially masking homologous endogenous receptors could be removed
and replaced with the flatworm receptor of interest. If co-transfected with a genetically-encoded
calcium or cAMP reporter (see [225] or [157] for reviews), this would be a robust platform for
the deorphanization of flatworm GPCRs.
5.0.1 Conclusion
Together, these chapters form a cohesive unit that develops and comments upon modern
techniques for anthelmintic development, but it also serves as a reminder that traditional bi-
ological experimentation remains the foundation of this field. The genomic age enables novel
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trajectories toward drug discovery while simultaneously reasserting a demand to more atten-
tive biological engagement with these animals. To advance understanding of these important
parasites, there must be the sort of multidisciplinary engagement that is demonstrated here.
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APPENDIX A. THE 50 HELMINTHS GENOME INITIATIVE (50HGI)
A paper to be submitted
Matthew Berriman1 et al., (Nicolas J Wheeler2,3, Tim A Day2,3)
This appendix includes selected sections for which I had primary responsibility in both the
analysis and textual summary.
Summary
GPCR Analysis
A comparative approach to identifying helminth GPCRs uncovered a number of fascinating
data (Figure A.1). First, the massive radiation of chemosensory GPCRs that occurred in C.
elegans is unmatched by any other nematode species. Indeed, over 87% of the C. elegans GPCR
complement is comprised of chemosensory GPCRs. In contrast, the next largest chemosensory
fraction occurs in the hookworm A. ceylanicum, comprising 30% of the total GPCR set. All
examined parasitic nematodes possess chemosensory receptors, with the greatest numerical
representation apparent in Clade V parasites. Although fewer chemoreceptors are found in
Clade I, III, and IV parasites, those present represent receptor subtypes that are near completely
conserved across all parasites in the phylum. These include homologs of C. elegans daf-37, which
is known to mediate ascaroside signaling, consistent with the importance of this pheromone
signaling pathway in the likely evolutionary transition from free-living dauer larvae to infective
larvae, the so-called dauer hypothesis [49, 145].
1Parasite Genomics, Wellcome Trust Sanger Institute, Hinxton, England
2Department of Biomedical Sciences, Iowa State University, Ames, IA USA
3Interdepartmental Genetics and Genomics, Iowa State University, Ames, IA USA
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There are distinctive differences between the GPCR complements of filarial nematodes and
non-filarial nematodes. Filarial nematodes (family Filarioidea) are phylogenetically diverged
from their counterparts and paraphyletic to the rest of Clade III. O. volvulus, L. loa, B. malayi,
and L. sigmodontis show an overall decrease in GPCR families and, on average, possess about
40% fewer GPCRs than their clade-mates.
One interesting contrast can be found in examination of the GPCR complements of Clade I
nematodes. It is seen that Trichinella spiralis and Trichuris muris have very similarly reduced
GPCR complements when compared to the non-filarial nematodes. In contrast Romanomermis
culcivorax appears to contain a more standard GPCR complement. In the R. culcivorax genome
paper [189], the authors performed a similar clustering analysis to the one performed here and
also noticed distinct differences within the proteomes of Clade I species. However, while they
surmised that T. spiralis is not representative of the rest of the clade, the GPCR analysis here
seems to suggest that it is actually R. culicivorax that stands out.
In regards to platyhelminths, it is seen that these worms express far fewer GPCRs than
nematodes overall, though many families are conserved in both phyla. There are, however,
a number of platyhelminth-specific groups, highlighted by the PROFs (Platyhelminth-specific
Rhodopsin-like Orphan Families) [236]. These receptors are Class A receptors and hypothesized
to be peptide responsive, but they do not show any significant homology to any annotated
or deorphanized proteins. Additionally, there are several families that are specific to flukes,
showing a cladistic GPCR expansion.
The two liver flukes C. sinensis and F. hepatica seem to lack any homolog to the classical
secretin receptor (Class B). Class B receptors are predominantly peptide hormone receptors
(glucagon receptor and parathyroid hormone receptor, for instance). Class B peptide hor-
mone receptors were found in more detailed searches of the S. mansoni and S. mediterranea
genomes [236], and these were recapitulated in this analysis, so it is interesting to discover that
this class of GPCRs has completely disappeared in the non-schistosome Digenea.
Interestingly, no chemosensory GPCRs are readily identifiable in platyhelminth species.
Given that flatworms, like nematodes, must navigate diverse environmental cues, it is likely
that these species do in fact engage in sophisticated forms of chemosensation. We hypothesize
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that either some subset of identified phylum-specific orphan receptors are involved in such
processes, or that chemosensation in flatworm parasites is not primarily driven by GPCRs.
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Figure A.1: Comparison of GPCR families for 81 nematode and platyhelminth species. Ne-
matodes (left) are organized by clade and platyhelminths (right) are organized by class. Each row signifies
an individual Compara family from the Ensembl comparative genomics pipeline.
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Cys-Loop Ligand-Gated Ion Channel Analysis
Several intriguing features can be seen in the comparative analysis of cys-loop receptors
in nematodes and platyhelminths (Figure A.2). All nematodes analyzed contain multiple sub-
units from the four previously described subfamilies of nicotinic acetylcholine receptor channels
(nAChRs; DEG-3, ACR-16, UNC-29, and ACR-8/UNC-38). In contrast, flatworms contain a
more restricted distribution that varies by class UNC-29-like and ACR-8/UNC-38-like for
cestodes and ACR-16-like for trematodes. These phyla also contain a previously described
flatworm-enriched family of divergent nicotinic acetylcholine anion channels that is not ho-
mologous to nematode ACCs, and we have expanded this family to additional flatworms. We
confirm that flatworms only contain one other family of anion channels - the GluCls of the
AVR-14 family.
While much is known about the cys-loop superfamily in nematodes, this group of important
proteins remains rich in unannotated and unstudied channels. This is particularly true of
flatworms, and the identification of these receptors will pave the way for in vivo and in vitro
studies to more fully appreciate their diverse and essential functions.
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Figure A.2: The phylogeny of cys-loop receptors in nematodes and platyhelmiths. MrBayes was
used to infer the phylogeny of the cys-loop superfamily in flatworms and nematodes. Posterior probabilities
were calculated from 8 reversible jump MCMC chains. Tree is rooted between nicotinic acetylcholine
receptors and non-nicotinic anion channels. Node posterior probability labels correspond to heatmap rows
in Figure A.3. List of species included is on x-axis of Figure A.3.
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Figure A.3: Comparison of cys-loop families for 81 nematode and platyhelminth species.
Families were extracted from the cys-loop phylogeny based upon posterior probability of clades. Taxa from
each clade were extracted, tallied, and organized in a heatmap.
Methods
Known, annotated GPCRs from C. elegans, B. malayi, O. volvulus, S. mansoni, and S.
mediterranea were identified from literature mining and previous GO annotations, and these
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were used as seeds for extraction of GPCR families created by the Compara pipeline. This
list of GPCR seeds included almost 2000 accessions: 1339 from C. elegans, 58 from B. malayi,
84 from O. volvulus, 150 from S. mansoni, and 343 from S. mediterranea. It was presumed
that the vast majority of the bona fide GPCR families could be identified from this set of
seeds, although species-specific, or possibly even clade-specific, duplications would have been
missed. These seeds were used to parse the Compara families, searching for any family that
contained at least one seed. A cursory examination of these putative GPCR families revealed
a substantial amount of false-positives, likely due to imprecise GO annotations by which the
seeds were curated.
A family-centric algorithm was then used to filter out false-positives and assign GPCR class
information. The sequence for each family member was extracted and families were aligned
with MAFFT [99] (mafft --auto), alignments were trimmed with trimal1.4 [35] (trimal
-automated1) to remove uninformative sites. Finally, HHSuite [171] was used to build an
HMM for each family and search (hhsearch) against databases of HMMs created by HHSuites
clustering algorithm (Uniprot [1], SCOP [10], Pfam [62], and PDB [17]). This strategy focused
on the conserved element of each family, likely the element that initially compelled Compara
clustering. The approach output best-hit information for each family against each of the 4
databases. Families supported as a GPCR by at least 2 databases were retained for downstream
analyses. To ensure proper designation and to assign classification, 2-5 random members from
each putative GPCR family was used in blastp searches against the non-redundant protein
database at the NCBI. All of the best-hit information was used to assign each family to one of
the GPCRDB classes (Class A, B, C, and F).
A similar approach was used for the cys-loop receptors. Known cys-loop receptor accession
IDs from C. elegans [94], Brugia malayi [120], Haemonchus contortus [27], Oesophagostomum
dentatum [27], and Schistosoma mansoni [129] were gathered and used to parse Compara fam-
ilies. The resulting families were concatenated to a superfamily, aligned with MAFFT [99]
(mafft --thread 4 --maxiterate 1000 --localpair fasta > alignment), and trimmed
with trimAl [35] (trimal -in alignment -out trimmed alignment -gt 0.85 -cons 2).
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A combinatorial approach was used to the infer the phylogeny of the superfamily. First, a
maximum-likelihood (ML) consensus tree was produced with RAxML (/raxmlHPC-PTHREADS-SSE3
-T 8 -x 12345 -p 12345 -U -# 100 -m PROTCATAUTO -s alignment -n name) by plotting
bootstrap values from 100 replicates onto the ML tree (/raxmlHPC-PTHREADS-SSE3 -f T -T
4 -p 12345 -m PROTCATAUTO -s alignment -n bestTree). To filter out taxa that reduced
the nodal support, RogueNaRok [2] was used to remove unstable rogue taxa. The subsequent
reduced alignment was then used to infer the phylogeny with MrBayes3.2 [182]. Two simulta-
neous runs, each with 4 reversible-jump MCMC chains, were allowed to proceed for 20,000,000
generations. The chain was given a temperature of 0.05 and took samples every 1000 genera-
tions. The parameters below were provided:
• prset shapepr=exponential(0.05);
• prset aamodelpr=mixed;
• lset rates=invgamma.
A 50% majority rule consensus tree that included all compatible groups was created from the
resulting 40,000 trees (sumt contype=allcompat), and this tree was visualized and annotated
with ggtree [233] (see Appendix B for a sample of the script used to process the tree). Cys-
loop subfamilies were redefined by selecting nodes with high posterior probability and using the
annotations of the original cys-loop seeds. A census of the tips of each subfamily was taken and
visualized in a heatmap with the ggplots2 [229] package within the R [83] statistical language.
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APPENDIX B. SELECTED PYTHON AND R SCRIPTS
Python Parser
1 #! usr/b in/python
2
3 with open ( ” seeds . txt ” , ” r ” ) as data :
4 search terms = data . read ( ) . s p l i t l i n e s ( )
5
6 missing terms = set ( search terms )
7
8 with open ( ” f a m i l i e s . txt ” , ” r ” ) as db , open ( ” output . txt ” , ”w” ) as output :
9 for l i n e in db :
10 for term in search terms :
11 i f term in l i n e :
12 missing terms . d i s ca rd ( term )
13 next l i n e = db . next ( )
14 output . write ( ”>” + head + ”\n” + next l i n e )
15 print ( ”Found {}” . format ( term ) )
16 break
17
18 i f missing terms :
19 d iagnose not found ( missing terms )
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Tree Plot
1 l ibrary ( ” ggp lot2 ” )
2 l ibrary ( ” gg t r e e ” )
3 l ibrary ( ”ape” )
4 l ibrary ( ” phytoo l s ” )
5 l ibrary ( ” phylobase ” )
6 l ibrary ( ” g e i g e r ” )
7 l ibrary ( dplyr )
8 l ibrary ( reshape2 )
9 l ibrary ( t i d y r )
10 l ibrary ( RColorBrewer )
11 l ibrary ( s t r i n g r )
12
13 palette <− colorRampPalette ( rev ( brewer . pa l (11 , ” Spec t r a l ” ) ) , space = ”Lab” )
14
15 setwd ( ”˜/Box Sync/ P r o j e c t s /50HGI/Wheeler/Tree” )
16 bayes f i l e <− ” c l−r j . con . t r e ”
17
18 bayes <− ape : : read . nexus ( bayes f i l e )
19 bayes <− bayes [ [ 1 ] ]
20
21 #load in r e f e r e n c e f i l e matching gene id <−> s p e c i e s <−> f a m i l y
22 r e f e r e n c e <− read . csv ( ” r e f e r e n c e . csv ” , header = FALSE)
23 colnames ( r e f e r e n c e ) <− c ( ”Gene ID” , ” Spec i e s ” , ”Family” )
24
25 #load in r e f e r e n c e f i l e matching s p e c i e s <−> c l a d e
26 r e f e r e n c e 2 <− read . csv ( ” c l ade s p e c i e s phylum . csv ” , header = FALSE)
27 colnames ( r e f e r e n c e 2 ) <− c ( ” Spec i e s ” , ”Clade” , ”Phylum” )
28
29 #gene id , s p e c i e s , fami ly , c l a d e
30 r e f e r e n c e <− merge( r e f e r e n c e , r e f e r ence2 ,by=” Spec i e s ” )
31
32 #add s p e c i e s name to t i p l a b e l , format :
S p e c i e s .”−”.Gene ID.”−”. Family .”−”. Clade .”−”. Phylum
33 t i p labels <− as . data . frame ( bayes [ ] $ t i p . l a b e l )
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34 colnames ( t i p labels ) <− c ( ” t i p l a b e l ” )
35 t i p labels <− t i p labels %>%
36 t i d y r : : s epara t e ( t i p l abe l , c ( ”Gene ID” , ”Family” ) , sep = ”−” , remove = TRUE)
%>%
37 s e l e c t (−Family )
38 r e f e r e n c e <− r e f e r e n c e %>%
39 f i l t e r ( Gene ID %in% t i p labels$Gene ID) %>%
40 group by( Gene ID) %>% d i s t i n c t ( . keep a l l=TRUE)
41 t i p labels$ id <− 1 :nrow( t i p labels )
42 t i p labels <− merge( t i p labels , r e f e r e n c e ,by=”Gene ID” ) %>%
43 arrange ( id ) %>% s e l e c t (− id )
44 t i p labels$ f i n a l l a b e l <−
paste0 ( t i p labels$Spec ies , ”−” , t i p labels$Gene ID , ”−” , t i p labels$Family , ”−” , t i p labels$Clade , ”−” , t i p labels$Phylum)
45
46 #r e p l a c e the o r i g i n a l t i p l a b e l s
47 bayes [ ] $ t i p . l a b e l <− t i p labels$ f i n a l l a b e l
48
49 #b a s i c t r e e wi th node l a b e l s
50 #g g t r e e ( bayes , branch . l e n g t h = ”none ” , l a y o u t = ” c i r c u l a r ”) +
geom t e x t 2 ( aes ( s u b s e t=! i sTip , l a b e l=node ) , h j u s t =−.3) + geom t i p l a b 2 ( )
51 #r e r o o t based on anion/ c a t i o n / r e p l o t
52 bayes <− phytoo l s : : r e r o o t ( bayes , 1252)
53 #Create a d f c o n t a i n i n g i n t e r n a l node numbers and probs , as w e l l as t e rmina l
node numbers and NA ( f o r l a b e l s )
54 prob <− dplyr : : f i l t e r ( as . data . frame ( bayes ) , i sT ip == FALSE)
55 prob <− dplyr : : s e l e c t ( prob , node , l a b e l )
56 prob$ l a b e l [ prob$ l a b e l == ”Root” ] <− NA
57 node <− c ( 1 : 11 22 )
58 l a b e l <− c ( rep (NA, 1122) )
59 prob2 <− data . frame ( node , l a b e l )
60 prob <− dplyr : : bind rows ( prob , prob2 )
61 colnames ( prob ) <− c ( ”node” , ”prob” )
62
63
64
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65 #############################
66 #c r e a t e e n t i r e g g t r e e o b j e c t
67 #############################
68
69 t <− ggt r e e ( bayes , branch . length = ”none” , layout = ” c i r c u l a r ” )
70 t <− ggt r e e : : r o t a t e ( t , 1127) %>% ggt re e : : r o t a t e (1129)
71
72 #add columns to t $data o b j e c t to i n c l u d e a l l metadata
73 df <− t i p labels %>%
74 rename ( l a b e l = f i n a l l a b e l )
75 t data <− t$data
76 t data replace <− merge( t data , df ,by=” l a b e l ” , a l l=TRUE) %>%
77 arrange ( node )
78 t$data <− t data replace
79
80 #add suppor t v a l u e s to nodes ( f o r manual s e l e c t i o n o f nodes )
81 #t b s <− t2 %<+% prob + geom l a b e l 2 ( aes ( s u b s e t=! i s . na ( prob ) , l a b e l = prob , f i l l =
prob ) )
82 #s e l e c t e d nodes based on suppor t v a l u e s
83 node <− c ( l g c45 = 1130 , mod1 = 1504 , ggr3 = 1429 , acc = 1530 , exp1a = 1409 ,
l g c37 = 1388 , unc49 = 1335 , ggr1 = 1127 , avr14 = 1206 , avr14a = 1207 , avr14b =
1258 , nsoa = 1643 , nsob = 2222 , nsoc = 2210 , nsod = 2166 , wso = 1654 , bna =
1992 , deg3 = 2012 , deg3a = 2067 , deg3b = 2021 , deg3c = 2087 , acr16 = 1707 ,
unc29 = 1938 , au838 = 1803 , acr8 = 1874 , unc38 = 1805)
84
85 #p l o t e n t i r e t r e e
86 t a l l <− t +
87 geom c l a d e l a b e l ( node=1429 , l a b e l=”GGR−3” , f o n t s i z e =8, of fset . text=1) +
88 geom c l a d e l a b e l ( node=1504 , l a b e l=”MOD−1” , f o n t s i z e = 8 , of fset . text = 1) +
89 geom c l a d e l a b e l ( node=1530 , l a b e l=”ACC−1” , f o n t s i z e =8, of fset . text=1) +
90 geom c l a d e l a b e l ( node=1336 , l a b e l=”EXP−1” , f o n t s i z e =8, of fset . text=1) +
91 geom c l a d e l a b e l ( node=1409 , l a b e l=”GAB−1” , f o n t s i z e =8, of fset . text=1) +
92 geom c l a d e l a b e l ( node=1388 , l a b e l=”LGC−37” , f o n t s i z e =8, of fset . text=1) +
93 geom c l a d e l a b e l ( node=1357 , l a b e l=”UNC−49” , f o n t s i z e =8, of fset . text=1) +
94 geom c l a d e l a b e l ( node=1130 , l a b e l=”LGC−45” , f o n t s i z e =8, of fset . text=2) +
94
95 geom s t r i p (509 , 343 , l a b e l = ”GGR−1” , f o n t s i z e = 8 , of fset . text = 4) +
96 geom s t r i p (54 , 351 , l a b e l=”AVR−14” , f o n t s i z e =8, of fset . text=7) +
97 geom s t r i p (1118 , 1102 , l a b e l = ”Nematode−S p e c i f i c Orphan” , of fset . text = 20 ,
f o n t s i z e = 8) +
98 geom s t r i p (540 , 1025 , l a b e l = ” N i c o t i n i c ACC” , of fset . text = 13 , f o n t s i z e = 8)
+
99 geom c l a d e l a b e l ( node=1992 , l a b e l=” Basal nAChR” , f o n t s i z e =8, of fset . text=5) +
100 geom c l a d e l a b e l ( node=2012 , l a b e l=”DEG−3” , f o n t s i z e =8, of fset . text=3) +
101 geom c l a d e l a b e l ( node=1707 , l a b e l=”ACR−16” , f o n t s i z e =8, of fset . text=1) +
102 geom c l a d e l a b e l ( node=1932 , l a b e l=”UNC−29” , f o n t s i z e =8, of fset . text=1) +
103 geom c l a d e l a b e l ( node=1805 , l a b e l=”UNC−38” , f o n t s i z e =8, of fset . text=1) +
104 geom c l a d e l a b e l ( node=1874 , l a b e l=”ACR−8” , f o n t s i z e =8, of fset . text=1) +
105 geom t i p p o i n t ( aes ( shape=Phylum , c o l o r=Phylum) , s i z e = 0 . 9 )
106 #Manually annotate : ” N i c o t i n i c A c e t y l c h o l i n e Receptor Channels ”
107
108 #s e l e c t which probs to show ( nodes p ick ed above )
109 prob3 <− prob [ prob$node %in% node , ]
110
111 t a l l <− t a l l %<+% prob3 + geom l a b e l 2 ( aes (na .rm=TRUE, l a b e l = prob , f i l l =
as . numeric ( prob ) ) ) +
112 scale f i l l g rad ientn ( colours = palette (11) , name=” P o s t e r i o r P r ob a b i l i t y ” ,
l i m i t s=c ( 0 , 1 ) ) +
113 theme ( legend . p o s i t i o n=” r i g h t ” )
114 t a l l
115
116 #############################
117 #c r e a t e g g t r e e s u b t r e e o b j e c t
118 #############################
119
120 t <− ggt r e e ( bayes )
121 t <− ggt r e e : : r o t a t e ( t , 1127) %>% ggt re e : : r o t a t e (1129)
122
123 #add columns to t $data o b j e c t to i n c l u d e a l l metadata
124 df <− t i p labels %>%
125 rename ( l a b e l = f i n a l l a b e l )
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126 t data <− t$data
127 t data replace <− merge( t data , df ,by=” l a b e l ” , a l l=TRUE) %>%
128 arrange ( node )
129 t$data <− t data replace
130
131 #add suppor t v a l u e s to nodes ( f o r manual s e l e c t i o n o f nodes )
132 #t b s <− t2 %<+% prob + geom l a b e l 2 ( aes ( s u b s e t=! i s . na ( prob ) , l a b e l = prob , f i l l =
prob ) )
133 #s e l e c t e d nodes based on suppor t v a l u e s
134 node <− c ( l g c45 = 1130 , mod1 = 1504 , ggr3 = 1429 , acc = 1530 , exp1a = 1409 ,
l g c37 = 1388 , unc49 = 1335 , ggr1 = 1127 , avr14 = 1206 , avr14a = 1207 , avr14b =
1258 , nsoa = 1643 , nsob = 2222 , nsoc = 2210 , nsod = 2166 , wso = 1654 , bna =
1992 , deg3 = 2012 , deg3a = 2067 , deg3b = 2021 , deg3c = 2087 , acr16 = 1707 ,
unc29 = 1938 , au838 = 1803 , acr8 = 1874 , unc38 = 1805)
135
136 #p l o t s u b t r e e based on node
137 node s e l e c t <− 1206
138 t c l ade <− t %>%
139 viewClade ( node=node s e l e c t ) +
140 geom t i p p o i n t ( aes ( shape=Phylum , c o l o r=Clade ) , s i z e = 2) +
141 geom text2 ( aes ( subset=! i sTip , l a b e l = l a b e l ) , s i z e = 1) +
142 #geom t e x t ( aes ( l a b e l=S p e c i e s ) , h j u s t =−.1, s i z e =3) +
143 geom text ( aes ( l a b e l=l a b e l ) , h ju s t =−.1, s i z e =3) +
144 theme ( legend . p o s i t i o n=” r i g h t ” )
145 t c l ade
146
147 #P u l l out nodes ( and c o l o r by Clade and l a b e l wi th s p e c i e s )
148 #haemonchus c o n t o r t u s g l c −1? H C O I 0 0 1 3 0 4 0 0 f a m i l y 1584651 V e N e m a t o d a
149 #we need avr−15
150 #avr−14 ( g lu−c l s )
151 #expansion w i t h i n nematodes a f t e r c l a d e I
152
153 #g e t c l a d e s f o r heatmap
154 des <− l i s t ( )
155 n <− 1
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156 for ( x in node ) {
157 y <− g e i g e r : : t i p s ( bayes , x )
158 des [ n ] <− l i s t ( y )
159 n <− n + 1
160 }
161 names( des ) <− names( node )
162
163 l en <− sapply ( des , length )
164 n <− max( l en )
165 l en <− n − l en
166 csv <− mapply ( function (x , y ) c ( x , rep ( NA , y ) ) , des , l en )
167 csv .m <− melt ( csv , na .rm = TRUE)
168
169 write . csv ( csv .m, f i l e=” c l a d e s . csv ” )
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